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1. GENERAL INTRODUCTION 
The search for a viral agent in the development of neoplasms in 
humans and animals has led to an enormous interest in and better under­
standing of the molecular biology of the RNA tumor viruses (1,2). These 
viruses have been shown to induce or to be associated with animal neo­
plasms of epithelial - (carcinomas), connective tissue- (sarcomas) or 
hemopoietic origin (leukoses). 
There is a close similarity between the various RNA tumor viruses 
with regard to structure, genome size and biological behavior irrespec­
tive of the animal species from which they are isolated. Thus, RNA tumor 
viruses contain a high molecular weight RNA (3-5) complexed with the 
reverse transcriptase (6). The virion buds from the cell membrane (7-10) 
and consists of an outer membranous envelope containing lipid and glyco­
proteins (11-17), and an inner core constituting the intermediate mem­
brane of the particles (core shell) surrounding the electron dense nu­
cleoid (the ribonucleoprotein complex) (10, 18, 19). This RNP complex 
consists of the high molecular weight RNA, the reverse transcriptase, 
and a small basic protein (5). 
The morphology of these viruses as revealed in the electron micro­
scope justifies the classification into three groups: A-, B-, and C-
type particles (1). C-type viruses induce leukoses and sarcomas in a 
variety of vertebrate species, while B-type particles provoke manmary 
carcinomas in mice and possibly other mammals. Both B- and C-type virus 
particles originate from an intracytoplasmic particle enclosed in a 
membrane, the Α-particle, which probably represents an immature form. 
The life cycle of RNA tumor viruses is as follows: The infectious 
particle attaches and penetrates through specific cellular receptor 
sites as a result of fusion of the virion membrane and host cell mem­
brane. In the host cytoplasm the RNA genome of the virus is transcribed 
by the viral reverse transcriptase into a double-stranded DNA provirus 
which is transported into the nucleus and integrates into the host cell 
genome. Viral RNA is synthesized by transcription of the provirus DNA 
in the nucleus and subsequently processed and transferred to the cyto­
plasm. This intracellular viral RNA serves as precursor of progeny 
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viral genome, and as mRNA in polyribosomes for the synthesis of viral 
proteins. The assembly of the viral particle occurs at the cell mem-
brane. By a budding process the virion is released from the cell sur-
face. Whereas in the last few years much progress has been made in 
tumor virus research, many questions about the possible mechanism of 
neoplastic transformation remain to be answered. An important problem 
is the virus-specificity of the virion proteins; in other words are 
they coded for by the viral genome or by the host cell in which the 
virion is assembled? Also the functions of the virion proteins are un-
known. For example, are they necessary as structural components or do 
they have functions in virus replication or in the control of expres-
sion of Miral-or'tiost genesTinvolved in neoplasttc transformation? 
As a direct approach to determine the coding capacity of the viral 
genome, .¿.e. the virus-specificity of the virion antigens, we have 
translated the virion RNA of avian myeloblastosis virus (AMV), a leu-
kosis-sarcoma virus, and Rauscher murine leukemia virus (R-MuLV) in a 
variety of cell-free systems and in living oocytes of the frog, Xenopu¿ 
LoüVJJiA. Only a part of the coding capacity of the viral genome is ex-
pressed in these systems as wil! be discussed later. 
1.1. ORGANIZATION OF THE VIRAL GENOME 
The principal nucleic acid component of the RNA tumor viruses is a 
single-stranded RNA molecule with a sedimentation coefficient of 60-70S 
(20) and an estimated molecular weight of 6-7 χ IO6 (21-24). This high 
molecular weight RNA has a considerable secondary structure (25, 26) and 
can be dissociated under conditions that disrupt hydrogen bonds into two 
subunits of 30-40S with a molecular weight of 3-4x10' (27-35) and smal­
ler heterogeneous RNA species (36-43). Measurements of the base sequence 
complexity of the viral genome have proven that the RNA tumor viruses 
contain a diploid genome, -t.e. both 30-40S RNA subunits are identica! 
(29-32,44). These 30-40S RNA subunits carry poly(A) sequences about 200 
nucleotides long at their З'ОН end (45-51). The S'end is blocked by 
7-methylguanosine (m7G) in the so-called cap sequence m 7G 5 ppp5 GmpCpCpA 
(52-55). About fifteen internal methylated bases are also present, pre-
10 
dominantly Ν6-methyl-adenosine (55). These properties have the viral sub-
units in coraron with a number of eukaryotic cellular messengers. 
Four genetic elements are located on the viral subunits of the non-
defective avian sarcoma viruses: a gene coding for the internal viral 
group-specific antigens (30g); a gene encoding the reverse transcriptase 
[poi); a gene coding for the viral envelope (glyco)proteins (em/), at 
least some of which determine the host range of the virus; and a gene for 
the sarcomagenic cell transformation (¿le or one) (56). Recently these 
biological functions were mapped on the viral genome on the basis of the 
distance of RNase Τ,-resistant oligonucleotides, specifying the different 
gene functions, from the 3' poly(A) end of the viral RNA. A unique ar­
rangement of oligonucleotides was found indicating that both subunits are 
similar in their sequence, and even a physical map has been constructed. 
The most l ikely complete map of these avian sarcoma viruses is 5' gag-po¿-
enu-¿/tc-poly(A) 3' (34, 57-60). A small heteropolymeric region of unknown 
function exists between the ¿лс gene and the terminal poly(A) (34). 
1.2. VIRUS-SPECIFIC STRUCTURAL PROTEINS 
By recent agreement (61) viral proteins below 30,000 are designated 
according to their apparent molecular weight in thousands, estimated af­
ter agarose gel f i l t r a t i o n in 6 M guanidine-HCl. Polyacrylamide gel elec­
trophoresis in SOS is applied for the estimation of the molecular weight 
of polypeptides above 30,000. Proteins are designated "p" and glycopro­
teins "gp". These viral proteins often possess multiple antigenic deter­
minants when examined in standard serological tests, namely group-speci­
f ic (shared by viruses of the same animal species), type-specific (unique 
to an individual virus strain), and interspecies-specific (shared by v i ­
ruses of different animal species). 
1.2.1. MURINE ТУРЕ-C VIRUSES 
Separation of the major structural proteins by gel f i l t r a t i o n or 
SDS gel electrophoresis reveals seven species: gp69/71, gp45, p30, pl5(E), 
pl5, pl2, and plO (61-66, 15). 
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1.2.1.1. Εηυζίορζ antig uni 
gp69/71 are the major glycoproteins, identified by incorporation of 
radioactive glucosamine (11, 12, 15, 17). They probably contain the same 
protein moiety but different sugar residues. The envelope localization 
of gp69/71 in the virion has been demonstrated utilizing selective tech­
niques to label the terminal carbohydrates of glycoproteins (69), and 
by enzymatic i odi nati on of viral surface proteins (70). The glycoproteins 
represent the knob-like projections that emanate from the external sur­
face of the viral membrane (10,67,68). A minor glycoprotein gp45 is in­
cidentally observed (12). The presence in gp69/71 of each of the three 
classes of antigenic determinants (type-, group-, and interspecies-) has 
been found by use of competition radioiimunoassay (71). The carbohydrate 
portion of gp69/71 is not of major significance in determining the immu­
nochemical properties of these glycoproteins (16,72,73). 
In addition to gp69/71 a low molecular weight polypeptide p/5(E)* 
is situated in or on the viral envelope (74, 75) but covered by the 
gp69/71 containing viral surface knobs (76). The polypeptide pl5(E) re­
acts interspecies- and group-specifically (71) in contrast to p/5 (77), 
localized in the interior of the virion. 
p72 is a phosphoprotein (78, 79) derived from pl5(E) (80,81). It 
binds specifically to the viral high molecular weight RNA (82). 
1.2.1.2. 1п£елпаІ antigeni 
The remaining structural proteins are all located within the enve­
lope of the virion (core structure). The viral cores can be obtained af­
ter treatment of the virus with non-ionic detergents (83). 
p30. The major internal structural protein is a component of the 
core shell (84). This protein contains group-, type- and interspecies 
antigenic determinants (85). Monospecific antisera against p30 have no 
virus-neutralizing activity. There is an amino acid sequence homology 
between the p30 molecules of several mammalian tumor viruses (86) which 
* "E" means envelope 
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means that they are products of related genes in viruses of different 
species. 
p15 is a basic protein and contains strong type-specific antigenic 
determinants besides group- and relatively minor interspecies determi-
nants. 
plO is an arginine-rich, strongly basic protein complexed with the 
viral RNA and reverse transcriptase in a ribonucleoprotein complex with-
in the viral core (6,84). The antigenic characterization shows a group-
specific activity (87). 
1.2.2. AVIAN l/IRUSES 
Only chick type-C viruses have been studied, and also these viruses 
contain seven protein species: gp85, gp35, p27, pl9, pl5, pl2, and plO. 
1.2.2.1. Envelope antigeni 
The surface projections of the avian tumor viruses are assemblies 
of two glycoproteins: gp85 and gp35 (88). The larger glycoprotein is the 
knob, and the smaller the spike portion of the surface projections (11, 
13). They are linked by disulfide bonds in a complex that contains one 
molecule gp85 and one molecule gp35 (89). The viral glycoproteins define 
the type-specific antigenicity and determine properties of viral host 
range, neutralization, and interference (11,13). 
plO, probably glycosylated, seems to be a component of the virus 
envelope. However, it has not been obtained antigenically active (84). 
1 .2 .2 .2 . IrvteAmZ <mtÍQzn¿> 
p27 is the major viral protein and constitutes the core shell (84). 
It contains group-specific antigenic determinants only (62,63,90). 
pI9 does not appear to be a constituent of the core and has not be 
detected at the virus surface (84). It might be located between core and 
virus membrane and possesses both group- and type-specific antigenic 
determinants (90). This renders it unlikely that it is the homologue of 
13 
the murine pl5(E) (74). 
p/5 contains the highest percentage of hydrophobic amino acid resi-
dues, tends to acquire a globular conformation, and might represent the 
capsomers on the core surface (84). Analysis of antigenic determinants 
reveals group- and type-specificity (90). 
p12 is a strong basic protein and, as the murine plO, complexedwith 
the viral high molecular weight RNA in a ribonucleoprotein structure (6, 
84). It also contains group- and type-specific antigenic determinants 
(90). 
Obviously there exists a great similarity in protein composition of 
both murine and avian tumor viruses. The same protein patterns are ob-
tained by various techniques, but also the functional role and serologi-
cal properties of the different equivalent proteins is evident. Most of 
these structural proteins must be encoded by the virus because they re-
tain their characteristic serological reactivities when synthesized in 
host cells of different species. Furthermore, when several strains of 
virus are grown in the same type of host cell, the peptide fingerprints, 
specific for the polypeptides of the particular virus strain, show the 
same characteristics (91-93). Further evidence for the virus-specificity 
is derived from data on the biosynthesis of viral proteins in virus-in-
fected cells and in cell-free systems. 
DESIGNATION OF AVIAN ANP MURINE TUMOR 
Locatiûn 
glycoproteins 
surface 
internal core shell 
nucleoprotein 
uncertain location 
Avian 
gp85, gp35 
plO 
p27, pl5 
pl2 
pl9 
VIRUS PROTEINS 
Милане 
gp69/71, gp45 
pl5(E), pl2 
p30, pl5 
plO, pl2 
pl2 
1.3. REVERSE TRANSCRIPTION OF THE VIRUS GENOME 
A number of enzymatic activities have been reported to be associated 
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with RNA tumor virus preparations (94), but probably many or all of these 
activities are associated with the outer envelope of the virus particles 
and are derived from the host cell. However, the reverse"transcriptase is 
complexed with the high molecular weight RNA within the viral core and is 
encoded by the viral genome as has been demonstrated by temperature-sen­
sitive mutants that harbor heat-labile polymerase activities (95,96). 
The reverse transcriptase can faithfully transcribe the viral RNA 
into complementary DNA (1,97). Purified reverse transcriptase also exhi­
bits a nuclease activity (RNase H) that selectively degrades the RNA 
moiety of an RNA-DNA hybrid (1,97,98). Both enzyme activities reside on 
the same polypeptide chain. The avian reverse transcriptase contains two 
subunits, α (with a molecular weight of 65,000) and 3 (with a molecular 
weight of 105,000) (99). The α subunit is derived from the В subunit by 
proteolytic action (100-102). In contrast, the murine reverse transcrip­
tase contains a single polypeptide chain of about 80,000 (103,104). 
During the early stages of infection the viral genome is transcri­
bed in the cytoplasm of the infected cell into a complete double-stranded 
circular DNA copy with a molecular weight of about 6 χ IO6 (105). For the 
reverse transcription of 30-40S RNA a unique 4S RNA is required as pri­
mer, and DNA synthesis proceeds by addition of mononucleotides at the 
3'0H end of the primer (106) which is covalently linked to the DNA copy 
(107). For avian viruses tRNA p has been identified as primer (108-112), 
whereas for the murine viruses tRNA p r 0 appears to be the primer for ¿n 
v¿üio DNA synthesis (ПО). Only one primer molecule is associated with 
each viral 30-40S RNA (113) at a site close to the 5' terminus (55,113, 
114). The 5' terminal DNA transcript contains nucleotide sequences com­
plementary to the 3' end of the viral genome, what probably means that 
5' and 3' termini of individual 30-40S RNA subunits contain repetition 
sequences that allow circularization of the RNA subunit (115). 
Unintegrated circular double-stranded proviral DNA synthesized in 
this way,has been demonstrated in cytoplasm and nucleus of virus-infect­
ed cells (105, 116-118), is infectious, and gives rise to progeny virus, 
indicating that DNA molecules of about 6 χ IO6 contain all the viral in­
formation (119). These circular molecules are the precursors of the viral 
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genome integrated in host nuclear DNA (120). Inhibition of integration 
results in an inhibition of virus replication (117, 121) and transfor-
mation of the infected cell (121). 
At least for AMV the provirus seems to be integrated at a specific 
place, namely in tandem with endogenous proviral DNA (122). This pro-
bably means that also for other RNA tumor viruses the integration of 
the provirus occurs at specific sites, and is restricted to a small 
number of sites. 
1.4. TRANSCRIPTION OF mRNA FROM INTEGRATED PROVIRAL DNA AND SYNTHESIS 
OF VIRAL PROTEINS IN VIVO 
In vivo studies on Rous sarcoma virus (RSV) RNA synthesis showed that 
viral RNA is synthesized in the nuclear fraction, and then transferred 
to the cytoplasmic fraction and virus particles (123, 124). Actinotny-
cin D as well as o-amanitin preferentially inhibit virus-specific RNA 
synthesis as compared to total RNA synthesis; an indication that the 
nucleoplasmic DNA-dependent RNA polymerase II is responsible for the 
transcription of viral messenger RNA (123-127). Whether the viral RNA 
is formed by cleavage of high molecular weight nuclear RNA and then 
processed, like cellular messenger RNA before transport to the cyto-
plasm, is unknown. However, several size-classes of viral RNA have been 
found both in the nucleus as well as in the cytoplasm of virus-infect-
ed cells (128-136). Predominantly two size classes of viral RNA have 
been found in association with membrane-bound and free polyribosomes, 
namely viral RNA of about 35S and 20S (130, 132, 135, 136) in addition 
to smaller species (132, 135). The messenger function of these viral 
RNA species has recently been proven (135, 137, 138). 
Since cells infected with tumor viruses continue to grow, spend-
ing only a small percentage of their protein synthetic activity to the 
synthesis of viral proteins, investigations on the virus-specific 
translation products require a specific probe. Immunoprecipitation 
techniques using polyvalent or monospecific antisera directed against 
the viral proteins are required to identify intracellular virus-speci-
fic polypeptides. Thus, Vogt and Eisenman (139) and Vogt ¿t ai (140) 
16 
found that some of the major internal structural proteins of AMV are de­
rived by cleavage from a common precursor (pr76). This precursor poly­
peptide could also be i d e n t i f i e d in vuvo by i n h i b i t i o n of protein clea­
vage by glucosamine (141). 
The major v i r a l glycoprotein gp85 was synthesized as an incomplete­
ly glycosylated precursor of 70,000 (p70) (16, 142). The processing of 
the avian precursor polypeptides is schematically for the internal struc­
tural proteins: 
pr76 -»• ргбб -»• ргбО —*· p27 
V .p l5 ^ pl9 NN р 1 Э 
^p l5 
and for the envelope glycoprotein: 
glycosylation 
p70 ^ gp85 
gp35? 
In cell productively infected with R-MuLV two unstable precursor 
polypeptides have been detected (73,81, 143-148): One precursor is gly­
cosylated (еи -рг82 (145) or pr90 (73)) and cleaved into gp69/71 and 
pl5(E). Upon inhibition of glycosylation a 70,000 molecular weight poly­
peptide is detected as precursor of the glycoproteins (73). A second 
precursor (pr75 (145) and pr65) (145, 73)) gives rise to the internal 
structural proteins. The same precursor pr65 accumulates in cells in­
fected with a temperature-sensitive mutant virus defective in protein 
cleavage at the non-permissive temperature (148). 
The processing of the murine virus precursor polypeptides is 
schematically for the internal structural proteins: 
pr75 •»• pr65 —•- p30 
^ pl5 
and for the envelope proteins: 
ewi>-pr82 — - gp69/71 and pl5(E) 
pr90 pl2 
The positions of gp45 and pio in this processing scheme are still un­
certain. 
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1.5. TRANSLATION IN VITRO OF TUMOR VIRUS RNA. 
A MODEL FOR THE FUNCTION OF VIRUS-SPECIFIC mRNA. 
Virion 30-40S RNA has all the characteristics of an eukaryotic mRNA. 
It has a "capped" 5' end, poly(A) at the 3 Ό Η end, and internal methylated 
bases (¿e.e. 1.1.)· Furthermore 30-40S virion RNA has the same sense as the 
virus-specific RNA in polyribosomes of infected cells and identical size. 
Therefore, we tried to translate virion RNA in pro- and eukaryotic protein 
synthesizing systems. However, in all systems tested as well as in oocytes 
of Xenopui Лаг іл only products related to the internal group-specific an­
tigens could be detected. This is an interesting observation because it 
is known from the physical map of the non-defective sarcoma viruses that 
the virion 30-40S RNA is a polycistronic messenger containing four gene­
tic elements probably located in the following gene order: 5' gag-po¿-
еп -глс-роІу(А) 3'. Since presumably no internal initiation takes place 
on eukaryotic polycistronic messengers, this observation would imply that 
protein synthesis probably starts at the initiation site at the 5' end 
of the 5' terminal gene, indicating that the gag-gene would be located 
at the 5' end of the virion 30-40S RNA. A termination site at the 3' end 
of the gag-gene then releases the ribosomes from the viral RNA. For the 
synthesis of the other viral gene products, subgenomi с messenger RNA 
species are apparently necessary, exposing the other initiation sites 
which are inactive in the viral 30-40S RNA. In virus-producing cells 
besides 30-40S RNA smaller viral messenger species have been detected 
which could act as functionally monocistrom'c messengers (137, 138). 
Whereas it is now well established that viral RNA can act as mes­
senger in various systems, several years ago the coding capacity of tumor 
virus RNA had still to be proven. Translation experiments in a cell-free 
system derived from E&diesUckia coti (E.coLL) programmed with viral RNA 
as described in Pubtication I, have proven that tumor virus RNA could act 
as messenger. Nevertheless at that time we did not succeed in translating 
viral RNA in mammalian cell-free systems. The reason for this failure 
might be the absence of specific factors necessary for the translation of 
viral RNA in several cell-free systems. We found, as has been shown in 
PubtccAtconi II and III, that upon partial purification of maimalian cell-
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free systems aspecif ic components, -i.e.. polyamines, which are necessary 
for the re l iab le t ranslat ion of eukaryotic and v i ra l messenger RNA, were 
los t . In PubLLcationi ÍV-V1I evidence for the translat ion of tumor virus 
RNA is presented. 
2 . 1 . PREFACE TO PUBLICATION I 
A.L.Ü. Gielkens, M.H.L. Salden, H. Bloemendal and R.N.H. Konings: 
"TnanilcutLon о^ опыделіс v-üuxl RNA and eukaAyotic теліе.пдел RNA -¿и the. 
E.coli cdUL-lKii ¿yitern". FEBS Lett. 28, 348-352 (1972) 
As already stated in chapter 1.5., 30-40S RNA isolated from pur i f ied 
vir ions of R-MuLV has a l l the properties of an eukaryotic messenger. Fur-
thermore, hybridizat ion experiments ident i f ied v i rus-speci f ic RNA sequen-
ces identical to those of the v i ra l genome in both cytoplasm and nucleus 
of virus- infected ce l ls (149,150). 
Riman et at (151) had already found an indicat ion for messenger ac-
t i v i t y of AMV-RNA in a ce l l - f ree system derived from E.coti, but no pro-
duct analysis had been carr ied out. Also Vidrine eX. at (152) found, upon 
programming with R-MuLV RNA, a stimulation of amino acid incorporation 
in a pa r t i a l l y pur i f ied ce l l - f ree system derived from vi rus- infected 
ce l ls . However, at that time we did not succeed in detecting virus-spe-
c i f i c polypeptides a f ter addit ion of v i ra l 60-70S or 30-40S RNA to c e l l -
free systems from rabbit ret icu locytes, from virus- infected c e l l s , or in 
oocytes from Хеиорол Ые -іь, due to the high endogenous a c t i v i t y of 
these mammalian systems. Meanwhile Siegert et al (153) reported the 
translat ion of AMV-RNA in an E.aoti c e l l - f r e e system into the internal 
gag-related products p27, p l 9 , pl5 and p l 2 , even in the same r e l a t i v e 
amount as found in the virus p a r t i c l e . In view of these results we t r i e d 
to translate R-MuLV - , AMV - , and mouse mamnary tumor virus (MMTV) RNA 
in a c e l l - f r e e system derived from E.coLL and found, upon SDS gel ana­
l y s i s , that only low molecular weight products specif ic for the or ig inal 
virus RNA were synthesized. In contrast g lobin-and α c r y s t a l l i n mRNA, 
excellent messengers in the eukaryotic c e l l - f r e e systems, were not trans­
lated in the E.cotL system. In agreement with our results Legon et ad 
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(154) were unable to detect any association of globin mRNA with E.coti 
ribosomes. However, addition of R-MuLV RNA resulted in the synthesis of 
a low molecular weight polypeptide that was later recognized as gag-
gene product pl5, whereas AMV-RNA programmed the synthesis of pl9, also 
a gag-related product. In the case of the avian viruses pl9 is the N-
terminal polypeptide in the gag-precursor pr76 (140, 155), and for 
R-MuLV probably pl5 (156). Because the gag-gene is probably the gene 
located at the 5' end of the viral 30-40S RNA, this would mean that the 
E.caLL system correctly initiates viral peptide synthesis upon addition 
of the viral RNA. Also imunoprecipitation analysis of the [3Ss]-methio-
nine-labeled polypeptides, synthesized under direction of R-MuLV RNA, 
with a polyvalent antiserum against R-MuLV revealed pl5 and three smal-
ler polypeptides that gave rise to identical tryptic maps (unpublished). 
Our results mean that the E.coti cell-free system correctly initia-
tes at the initiation site of the gag-gene located at the 5' end giving 
rise to the synthesis of the N-terminal gag-gene product. However, pos-
sibly due to E.coti RNase activity, the viral RNA is degraded and, the-
refore, no complete gag-precursors have been synthesized. 
In view of this interpretation it is difficult to reconcile our 
experimental evidence with those obtained by Siegert et at (153) and 
Twarzik e£ at (157). The latter authors found in addition to smaller 
polypeptides "p30" as predominant product in an E.coLL system program-
med with AKR viral RNA. The discrepancies in molecular weights of the 
viral polypeptides synthesized in an E.coll system, which have been 
found by several authors, may be due to the different analytical methods 
used for detecting virus-specific products. We employed autoradiography 
of gel electropherograms which gives a very high resolution, whereas the 
other groups sliced the gels to detect radioactive bands. In our auto-
radiographs a number of minor bands are detectable in the 30,000 molecu-
lar weight region of the SDS gels. This radioactivity may be responsible 
for the "30,000 molecular weight polypeptide" detected upon gel slicing. 
Nevertheless, agreement exists about the presence of low molecularweight 
polypeptides related to the internal gag-proteins of the virions. 
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2.2. PREFACE TO PUBLICATIONS II AND III 
M. Salden, T. Bisseling, Α. Berns and H. Bloemendal: 
"ReqtuAwnent oí a dLaZyzcLblz component íwm anude. ¿nitititLon іасХолл ¿о*. 
the. tULn&ùiuUon oí ілаі and шкалуо&с теллепдел RNA". Biochem. Biophys. 
Res. Commun. 65, 317-322 (1975) 
M. Salden and H. Bloemendal: 
"PoZyanUneA can Ke.pla.ce. the dAjaZ.yza.btt component ínxim exude fietiailocyte 
¿nitiatÍon íactou". Biochem. Biophys. Res. Coimun. 68, 157-161 (1976) 
Whereas we were able to translate tumor virus RNA in an E.co¿¿cell-
free system, no v i rus-speci f ic products were detectable upon prograimiing 
mammalian ce l l - f ree systems with v i ra l RNA. Only the group of Arlinghaus 
(152) reported the stimulation of amino acid incorporation upon addit ion 
of R-MuLV RNA in a ce l l - f ree system derived from virus- infected ce l l s . 
However, no product analysis had been performed. The same group (158) 
found that binding of R-MuLV RNA to ribosomes was dependent upon addi-
t ion of i n i t i a t i o n factors derived from polyribosomes of v i rus- infected 
ce l l s . Therefore, we could not exclude the poss ib i l i t y that speci f ic 
binding factors were required for the binding of v i ra l RNA to ribosomes, 
and for the synthesis of v i rus-speci f ic polypeptides. 
Factors responsible for selective binding of specif ic mRNAs to r i -
bosomes had been reported by Heywood's group (159, 160). Messenger-spe-
c i f i c i n i t i a t i o n factors , necessary for protein synthesis directed by 
g lob in - and v i ra l mRNA had also been found byWigleand Smith (161,162) 
and Nudel e i at (163). In addition to these speci f ic protein fac tors , 
thought to be involved in the translat ion control of protein synthesis 
by v i ra l and eukaryotic messengers, a number of investigators had sug-
gested the poss ib i l i t y that RNA molecules may also be responsible for 
t ranslat ion control by d i rec t ly ef fect ing the i n i t i a t i o n of protein syn-
thesis. This idea was based upon the observed inh ib i t i on of the rate of 
i n i t i a t i o n of protein synthesis af ter addit ion of actinomycin D to eu-
karyotic cel ls (164-166). Fuhr and Natta (167) found a low molecular 
weight RNA factor in the u l t r a f i l t r a t e of the 0.5 M KCl wash of re t i cu -
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locyte ribosomes, that stimulated the synthesis of 0-globin, but inhibi­
ted the synthesis of a-globin. More recently, however, they reported on­
ly a stimulatory effect of this low molecular weight RNA upon translation 
of homologous mRNAs (168). Likewise Bogdanovsky еЛ al (169) isolated a 
small RNA species that could restore the activity of the dialyzed initia­
tion factor preparation from rabbit reticulocytes. Berns eí al (170) did 
not find any specificity of this low molecular weight RNA towards globin 
or crystallin messengers but only a non-specific stimulation of cell-free 
protein biosynthesis. 
In contrast, Heywood oX at (171) isolated a low molecular weight 
species by dialysis of an IF-3 fraction from muscle cells, which was 
termed translational control RNA (tcRNA). This species specifically in-
hibits the translation of heterologous mRNAs. The inhibition after addi-
tion of this tcRNA to the cell-free system may result from the inability 
of heterologous mRNA to bind to ribosomes during the formation of an 
initiation complex (172). Meanwhile two classes of tcRNA have been ob-
tained; one from messenger ribonucleoprotein, the other from polysomal 
sources, both inhibiting heterologous mRNA translation (173). These re-
sults are interpreted by the authors in that translational control of 
protein synthesis in eukaryotic cells may involve both positive (protein 
initiation factors) and negative (low molecular weight RNA) control ele-
ments. 
In view of these results we assayed the requirement of a dialyzable 
component for the translation of viral and eukaryotic messenger RNAs. 
However, we observed only an aspecific stimulation of both homologous 
and heterologous messengers. Moreover, a dialyzable factor with similar 
properties as the reticulocyte factor has been isolated from Krebs asci-
tes tumor cells. Further studies made the RNA character of this component 
doubtful. 
Meanwhile several papers appeared in the literature dealing with the 
aspecific stimulatory activity of polyamines in manrialian cell-free sys-
tems (174-178). These polyamines are universally distributed in all li-
ving organisms, and as strong bases they have a high affinity for anionic 
components and interact especially with nucleic acids. They may play a 
role in the regulation of protein biosynthesis because they stimulate 
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various steps in polypeptide synthesis as aminoacylation of tRNA, binding 
of mRNA to ribosomes, and binding of aminoacyl-tRNA to ribosomes (175, 
178, 179). 
Polyamines are non-covalently bound to ribosomes and this may be the 
most important site of action of polyamines (180). They can be released 
from these ribosomes by adding increasing amounts of mono- or divalent 
cations. Thus, it is possible to remove polyamines from polyribosomes in 
the high salt wash (0.5 M KCl) fraction. When this latter fraction is 
dialyzed, the polyamines would accumulate in the dialysate and might ex-
plain the biological activity of that fraction. In fact, we could mimic 
this activity (¿ее PubLLccUxon III) by adding to the cell-free systems 
polyamines instead of the dialyzable component(s) of the ribosomal high 
salt wash. Other groups also obtained aspecific stimulation of homologous 
and heterologous mRNA translation upon addition of polyamines (181, 182). 
We were able to detect a polypeptide of 72,000, synthesized under 
direction of denatured R-MuLV RNA, in the reconstituted messenger-depen­
dent reticulocyte cell-free system (183-185) in the presence of poly­
amines. In a continuation of these studies we translated tumor virus RNA 
in several cell-free systems and we were able to detect virus-specific 
polypeptides by means of immunoprecipitation (144) and scintillation auto­
radiography (186) in all systems tested. 
Taken together, these well comparable results obtained with diffe­
rent systems are in agreement with the notion that no specific factors 
are required for the translation of R-MuLV RNA. That this conclusion ap­
parently also holds for any other eukaryotic cellular or viral mRNA fol­
lows from the bulk of recent publications in this field. 
2.3. PREFACE TO PUBLICATIONS IlZ-fll 
M.H.L. Salden, A.L.J. Gielkens and H. Bloemendal: 
"Τnam, latió η o¡$ Каилскел leukemia ілил RWA in hetesiologoui ceZl-i>ie.e 
by&tenu". Biochim. Biophys. Acta 425, 208-219 (1976) 
M.H.L. Salden and H. Bloemendal: 
"Tfiamlation o^ avian myeZoblaòtoiiA ілш, RNA in a ivtieulocyte. ceZl-
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¿лее ¿yitem". Biochem. Biophys. Res. Commun. 68, 249-255 (1976) 
M. Salden, F. Asselbergs and H. Bloemendal: 
"TnaniùvUon o£ oncogenic, vlnrn RNA in Хеиорол Ыг іь oocytti". Nature 
259, 696-699 (1976) 
M.H.L. Salden, A. Sel ten-Versteegen and Η. Bloemendal: 
"TftanòlatiOn o£ Пашскел тиліпг leukemia, vinai RWA. A modeZ ion. the ¿unc-
tion 0(J ілаі-іресАііс тел&епдел". Biochem. Biophys. Res. Commun. (1976) 
(in the press) 
In order to determine the coding capacity of tumor virus RNA we 
t r i e d to translate R-MuLV and AMV-RNA in a number of mammalian c e l l - f r e e 
systems and in oocytes from Xenopui £aevi&. As already stated in chapters 
1 and 2, the v i ra l RNA contains a number of properties of an eukaryotic 
messenger and could function as such in an E.co&L ce l l - f r ee system. 
Analysis of v i rus-spec i f ic protein synthesis in v i rus- infected ce l ls 
with an antiserum prepared against pa r t i a l l y disrupted virus had already 
revealed that tumor virus proteins were formed by post- translat ional 
cleavage of large precursors (139, 146). Thus, AMV internal structural 
gag proteins are formed by sequential cleavage of a common gag-precursor, 
pr76, and even the arrangement of the v i r ion polypeptides in th is gag-
precursor is determined (140, 187). The major AMV glycoprotein gp85 is 
synthesized as an incompletely glycosylated precursor of 70,000 molecular 
weight (16). 
R-MuLV protein synthesis in vivo also revealed several unstable pre-
cursor polypeptides, the gag-precursors pr75 and pr65, and the envelope 
precursor eiw;-pr82. The gag-precursor pr65 is cleaved into the internal 
structural proteins p30 and p l5 , and the envelope precursor in the major 
glycoproteins, pl5(E) and pl2 (73, 144, 145, 147, 148, 188). The same imrnuno-
prec ip i ta t ion techniques have proven to be of value for the analysis of 
the v i rus-speci f ic polypeptides synthesized in mammalian ce l l - f ree sys-
tems. 
In vitio t rans la t ion of RSV-RNA gave r ise to the synthesis of a 
gag-related precursor polypeptide with a molecular weight of 75,000-
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80,000 (189). R-MuLV RNA translated in a c e l l - f r e e system derived from 
virus-infected ce l ls led to the appearance of two classes of v i r a l pro­
teins in the 50,000-75,000 and 140,000-180,000 molecular weight range 
(190). We were able to translate R-MuLV RNA in a variety of mamalian 
c e l l - f r e e systems and found upon imnunoprecipitation and SDS gel analy­
sis two precursors, pr72 and pr65, as predominant products (лгг. PabtL-
cation I f ) . A band in the 50,000 molecular weight region also present 
may be p a r t i a l l y aspecif ic as i t migrates in a gel region distorted by 
large amounts of IgG heavy chain or ig inat ing from the antibody present 
in the immune complex. Meanwhile the 15,000 molecular weight band has 
also been proven to be p a r t i a l l y aspecific as i t has been found in a 
variable amount in control ret iculocyte c e l l - f r e e incubations. 
Nevertheless, evidence for the v i r u s - s p e c i f i c i t y of the other 1m-
munoprecipitable polypeptides arose from the comparison with the trans­
la t ion products of AMV (VabtLcouUoni V and l/I). AMV-RNA directed the 
synthesis of both pr76 and pr66 and the internal structural polypept i­
des p27, p l 9 , p l 5 , and p l2. I t has to be mentioned that cleavage of 
precursors into structural polypeptides has only be detected in one 
part icular ret iculocyte lysate preparation. As a rule oncogenic virus 
RNA is translated in c e l l - f r e e systems into precursor polypeptides only 
(?іхЫісд£іоп. I/I). However, in these mammalian c e l l - f r e e systems neither 
glycoproteins nor glycoprotein precursors had been detected. 
Gielkens dt at (135) have found that c e l l u l a r membrane fract ions 
may be necessary for the synthesis and glycosylation of the envelope 
precursor. Therefore, we investigated the synthesis of v i rus-speci f ic 
polypeptides "-¿и vivo" by in ject ion of tumor virus RNA into l i v i n g oo­
cytes of Xenopu¿ ¿a.e.v.ii (VubLLcntLon V I ) . Nevertheless, both R-MuLV and 
AMV-RNA gave r ise to the synthesis of gag-related precursors that were 
pa r t i a l l y cleaved into the internal structural polypeptides, an indica-
t ion that host-cel l enzymes are responsible for th is cleavage. This re-
sul t is very remarkable: i t reveals the occurrence of highly specialized 
enzymes that attache the same very speci f ic structures in remotely re la-
ted animals. Careful analysis with monospecific antisera directed against 
gag- and eiw-products substantiated that only gag-related products were 
synthesized {PubLLccutLon l / I I ) . Kerr c i aZ (191) have recently published 
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similar results for the translation of Moloney murine leukemia virus in 
marmali an cells. 
However, the viral genome contains several genetic elements, and the 
most probable gene order for the non-defective avian sarcoma viruses is 
S'-gag-poZ-e.w-iKc-polyiW-Z' (chapter 1.1.)· The translation products of 
these genetic elements, with exception of the ¿лс-gene, have been detect­
ed in vi rus-infected cells. Therefore, it has to be established by what 
kind of mechanism the different gene products are synthesized ¿n vivo. 
Three models are proposed: 
a) The RNA of genome size acts as a polycistronic messenger; this means 
that it has multiple initiation and termination sites, one for each 
genetic elements (192). 
b) The RNA of genome size has only one initiation site. In that case a 
large polyprotein is synthesized and subsequently cleaved by specific 
proteases (193). 
c) The RNA of genome size is processed by specific nucleases to form 
functionally monocistronic messengers or the monocistronic messenger 
is formed by incomplete transcription of the DNA (194-197). 
Functionally monocistronic means that it contains more cistrons; however, 
only one cistron is available for translation. 
In the case of the tumor viruses model c) offers the most probable 
mechanism for synthesis of viral proteins and regulation of viral gene 
expression. Actually, several groups have found that virus-specific RNA 
molecules, smaller than the virion 30-40S RNA but containing nucleotide 
sequences derived from this virion RNA, are present on polyribosomes of 
virus-infected cells (128-136). Recently Gielkens zt al (135) have shown 
that these RNA molecules can function as messengers in a reticulocyte 
cell-free system. For example, the 20S virus RNA isolated from polyribo-
somes of infected cells is probably the messenger for the non-glycosyla-
ted envelope precursor. Two other groups have substantiated these find-
ings by using monospecific antisera against the purified viral envelope 
(137, 138). 
Our results prove that the virion 30-40S RNA behaves as a monocis-
tronic messenger for the synthesis of the gag-gene products. However, а 
readthrough mechanism might be responsible for the small amount of the 
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high molecular weight precursor observed upon programming a reticulocyte 
lysate with virion 30-40S RNA. This high molecular weight precursor pos­
sibly contains the gag-precursor covalently linked to the reverse trans­
criptase. Since presumably no internal initiation of protein biosynthesis 
takes place in eukaryotic cells, our results would imply that the gag-
gene is located at the 5' end of the 30-40S RNA. 
For the synthesis of the envelope products a novel monocistronic 
messenger has to be formed. Since no processing of virus RNA into smaller 
(functionally) monocistronic messengers occurred after injection of 30-
40S RNA into the nucleus of oocytes from Кгпорил ¿a.&v¿i, we favor that 
partial transcription of the proviral DNA might be the mechanism by which 
these viral messengers are formed (198). 
Monocistronic or functionally monocistronic messengers offer the 
possibility for the independent control of the expression of the diffe-
rent viral genes. 
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1. Introduction 
Recently several studies have been published which 
describe the faithful translation of animal messenger 
and viral-RNA in eukaryotic cross systems [1-12]. 
Although stimulation of ammo acid incorporation 
by viral RNA or eukaryotic messengers m bac te nal 
cell-free systems has been reported, reliable translation 
has only been described incidentally [13—19]. 
We compared the translation of eukaryotic- and 
oncogenic viral-RNA's in the cell-free system off. colt 
with that of the reticulocyte lysate. Our results provide 
evidence that in the bacterial system the viral RNA's 
are translated mto several distinct polypeptides, where­
as no indication for the translation of eukaryotic mes­
sengers could be obtained. Moreover, addition of the 
viral RNA's to the mammalian systems described, ap­
peared not to result m translation. 
2. Materials and methods 
Rauscher leukemia virus (RLV) was isolated from 
the plasma of leukemic mice as described [20]. Punfied 
mouse mammary tumor virus (MTV) from mammary 
tumors of (СЗН/HeA X 020)F1 mice was a generous 
gift of Dr. P. Hageman. After incubation of the virus 
with pronase m the presence of SDS the viral RNA's 
were extracted with chloroform-phenol [21, 22].-The 
60 S component of RLV-RNA was isolated by centn-
fugation in isokinetic glycerol gradients (15.0—30.2%, 
w/v). Denaturation of RNA was performed in 3 mM 
KCl for 3 mm at 65° [23]. After heating and rapid 
cooling the RNA preparations were immediately test­
ed for then messenger activity. Globm 9 S and a-crys-
tallin 14 S mRNA were a gift of Dr. A. Berns. Mono­
layers of mouse spleen- and thymus-cells (JLS-V5) 
were used for the propagation of radioactive-labeled 
RLV. Tbe JLS-V5 cell Ime was a generous gift of Dr. 
W. Schäfer. The preparation of phage M12 RNA and 
of the cell-free system off. colt has previously been 
described [24]. The incubation mixture contained per 
ml SO nmoles of each of the added unlabeled ammo 
acids, 10 jnnoles magnesium acetate, 50 Mmoles Tris-
HC1, pH 7.8, TOjimoles NH4CI, Sjimoles 2-mercapto-
ethanol, 0.25 mg E colt tRNA, 5 /«noies ATP, 0.3 
/andes GTP, 5 /mióles PEP, 8 μg pyruvate kinase, and 
0.24 ml of pre-mcubated S-30. The amounts of RNA 
and radioactive label added to the system are given m 
the legend of table 1. After 30 mm of incubation at 
37°, 10μΙ aliquots from the incubation mixture were 
removed for the estimation of total protein synthesis 
by precipitation with TCA. The remainder was treated 
with pancreatic RNAase and analyzed by electropho­
resis on 12.5% SDS-polyaciylamide gels [25]. 
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3. Results and discussion 
3.1. Effect of wal RNA and eukaryotic mRNA on 
ammo acia incorporaron 
Addition of either RLV-RNA or MTV-RNA to the 
cell-free system ofE. coll resulted in a significant stim­
ulation of the amino acid incorporation (table 1). When 
equal amounts of RLV- and MTV-RNA were tested, the 
stimulatory effect of the latter was always more pro­
nounced. An even higher stimulation could be obtain­
ed if instead of total RLV-RNA the purified 60 S RNA 
component was added to the system. This is probably 
due to an inhibitory effect of the low molecular weight 
viral RNA ( 4 - 5 S), present in the virion, on the transla­
tion of 60 S RLV-RNA. Evidence for this assumption 
was denved from the fact that this low molecular 
weight RNA fraction also inhibited the translation of 
phage M12 RNA (cf [26] ). Denaturation of RLV-
RNA consistently resulted in an additional stimulation 
of the ammo acid incorporation, while denaturation 
Table 1 
Stimulation of amino acid incorporation by vital RNA and 
eukaryotic RNA preparations in the cell-free system of £ CO/L 
Exp. I Exp. II 
RNA added ["clamino RNA added I^SJmelhronme 
acid (cpm (cpm incoipoialed) 
incorporated) 
None SS8 None S820 
Phage M12 12,693 Phage M12 138,866 
RLV 1058 (2010)* RLV 8784(14,398) 
RLV 60 S 1928(2749) Globin 9 S 8960(10,102) 
MTV 2033 C386) o-crystaUm 
Ribosomal 14 S 6506 (7290) 
18 S 604 
Ribosomal 
2BS 613 
To each 60 μΐ incubation mixture, m experiment 1,4 Mg RNA 
and 5 мСі lMC]ammo acid mix tuie (54 Cl/mg-atom of carbon) 
was added. In experiment II, to each 60 μΐ incubation mixture 
5 Mg RNA and 8 vCi [^SJmethlonme (32 Ct/mmole) was added. 
After 30 mm of incubation al 37° the reaction was terminated 
by the addition of 60 μΐ of 0.025 M EDTA and TCA precipit-
able radioactivity was deteimmed m 10 μΐ aliquols of the incu­
bation mixture. 
* Values obtained after denaturation of the RNA are given m 
parentheses. 
of MTV-RNA was much less effective. For comparison 
the effect of several distinct eukaryotic mRNA prepa­
rations on the amino acid incorporation was studied. 
Addition of globin 9 S mRNA resulted m a stimulation 
of the ammo acid incorporation which could be enhanc­
ed by denaturation. The effect of lens 14 S mRNA, 
codmg for the A]-chain of o-crystallm, was almost 
negligible. 
No significant stimulation could be observed after 
addition of either 18 S or 28 S ribosomal RNA to the 
cell-free system. 
3.2 Analysis of the m vitro products by SDS Polyacryl­
amide gel electrophoresis 
From the results presented m fig. 1 A it can be con­
cluded that addition of native RLV-RNA to the cell-
free system gives rise to the synthesis of a number of 
distmct polypeptides. Co-electrophoresis of these poly­
peptides with the proteins derived from the virion in­
dicated that at least those migrating m the low molec­
ular weight range (slice no. 52—71) coincide with the 
native viral proteins (fig. 1 B). Furthermore additional 
polypeptides are synthesized which migrate in the 
30,000 dalton region (slice no. 3 2 - 4 0 ) . The effect of 
denaturation of RLV-RNA on the translation is strik­
ing. This resulted m the appearance of a high molec­
ular weight polypeptide (slice no. 24—27) which is 
only present m trace amounts m the control experi­
ment In order to obtain more accurate data about the 
size and number of the synthesized polypeptides, auto­
radiographic analysis on dried gels was performed. In 
fig. 2 A, the autoradiogram of the polypeptides syn­
thesized under the direction of denatured RLV-RNA 
is shown (b). For companson, the gel pattern of label­
ed viral proteins is also depicted (c). It may be conclud­
ed that denatured RLV-RNA mainly gives nse to the 
synthesis of two polypeptides, REo and REj, with 
molecular weights of approx. 45,000 and 15,000 dal­
lons, respectively. The electrophoretic mobility of the 
polypeptide RE2 is identical to that of the native pro­
tein R2. It might be possible that the polypeptide REo 
is identical to one of the minor viral proteins present 
m the 45,000 daltons region. No clear indication could 
be obtained whether a polypeptide of the same size as 
the viral protein R, (gs 1) was synthesized. Further­
more several faint bands are visible of which at least 
some seem to have no corresponding polypeptide syn-
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H-hiatidine cpm 
A 
C-ammo acid срткЮ"^----· 
а
 • . H h i s t i d i n e срті« Ю - 2 
SO 80 
elice number 
60 SO 
elice number 
Fig. 1. SDS gel analysis of the polypeptides synthesized under direction of RLV-RNA. A) Polypeptides synthesized in the absence 
(o - - о - - о) and presence ( · — · — · ) of RLV- RNA. В) Companson by co-electrophoresis of the polypeptides synthesized іл vitro 
under the direction of denatured RLV «RNA ( · — · — ^ ) with the viral proteins labeled with ( 14C1 ammo acids (o · - o- - o). incu­
bation m the presence of [3H]hutidine. Aftei electrophoress the gels were sliced m 1 mm sections. To measure the radioactive 
labels separately the dried gel slices were processed with the aid of the Tn-Carb Sample Oxidizer (Packard Model 305). 
thesized in the endogenous system. 
As the RNA present in the RLV virion consists of 
several RNA species, experiments were performed to 
investigate whether there exists a difference between 
the polypeptides synthesized under the direction of 
total RNA and the purified 60 S RNA component. 
Analysis of the in vitro products showed that both 
RNA preparations directed the synthesis of the same 
polypeptides (fig. 2 В, a—c). From these results it may 
be concluded that the RNA component sedimenting 
in the 60 S region contains all the genetic information 
necessary to code for the polypeptides synthesized in 
the in vitro system. 
Evidence for the reliability of the in vitro transla­
tion of RLV-RNA can be derived from the observation 
that under direction of RNA isolated from the non-
related mouse mammary tumor vims (MTV) quite dif­
ferent polypeptides are synthesized. MTV-RNA directs 
the synthesis of at least one polypeptide MEt which 
coincides with one of the native MTV proteins (Р6 ), 
(fig. 3 A, a—c). This polypeptide migrates slightly 
faster than the RLV-RNA directed polypeptide RE2. 
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Fig. 2. Autoradiograms of the polypeptides synthesized under the direction of RLV-RNA and separated by SDS gel electrophoresis. 
A) Products of the endogenous £". coli system (a); with denatured RLV-RNA (b); RLV proteins labeled with [14C] amino acids (c). 
В ) Products of the endogenous £ coli system (a); with RLV-RNA (b);with denatured RLV-RNA (c); with the 60 S RLV-RNA com-
ponent (d); with the denatured 60 S RLV-RNA component (e). Incubation in the presence of [ 14C | ammo acids. 
p 6 -
i 
Ш 
il -ME 
-RE, 
ijyijsÉ 
IÌ-
-RE„ 
I ^ ^ Я Н ЯШ 
a toc d e f a b e d e f g 
Fig. 3. A) Autoradiograms of the polypeptides synthesized under the direction of MTV- or RLV-RNA and separated by SDS gel 
electrophoresis. Native MTV proteins stained with Coomassie blue (a); in vitro system supplemented with MTV-RNA (b), with de­
natured MTV-RNA (c); without RNA (d); with RLV-RNA (e); with denatured RLV-RNA (f). Incubation in the presence of [ 14C] 
amino acids. B) Autotadiograms of the polypeptides synthesized under the direction of globin 9 S and a-crystallin 14 S mRNA. 
Products of the endogenous £". coli system (a); with globin 9 S mRNA (b); with denatured globin 9 S mRNA (c); with ûr-crystallin 
14 S mRNA (d); with denatured a- crystallin 14 S mRNA (e); with native RLV-RNA (0; with denatured RLV-RNA (g), a stands 
for o-crystallin, g stands for globin. Incubation in the presence of [3sS]methìonìne. 
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Denaturaüon of MTV-RNA does not result in the syn-
thesis of an additional polypeptide (c) as has been ob-
served in the case of RLV-RNA (0· There is a striking 
discrepancy between the distribution of radioactivity 
of polypeptides synthesized under the direction of 
MTV-RNA as compared with those synthesized under 
the direction of RLV-RNA (compare b, с with e and f)-
Furthermore, m case of MTV-RNA a pronounced 
synthesis of polypeptides which migrated with the 
buffer-front could be observed (b, c). The reason for 
this may be that, although there is a high rate of initi­
ation, the completion of polypeptides is inefficient. 
In order to examine whether eukaryotic mRNA 
preparations are faithfully translated we studied the 
effect of addition of a-crystallm 14 S and globin 9 S 
mRNA to thef. coll cell-free system. From fig. 3 В 
it may be concluded that both mRNA fractions do 
not give rise to the synthesis of their encoded proteins 
(b—e). Only low molecular weight polypeptides seem 
to be synthesized. As suggested above this may be due 
to the fact that protems are initiated but, for reasons 
still unknown, not completed. In this connection it 
should be mentioned that under conditions m which 
globin- and a-crystal!in-mRNA are translated very 
efficiently in a reticulocyte cell-free system and in 
oocytes, until now in both systems no evidence could 
be obtained for the translation of RLV-RNA (experi­
ments in collaboration with Dr. J.B. Curdon, Unpub­
lished). In the reticulocyte system only a strong inhibi­
tion of globin synthesis, up to 85%, could be observed. 
Although a 0.5 M KCl-wash denved from polysomes 
of leukemic spleens stimulated the endogenous globin 
and a-crystallm synthesis, no indication could be ob­
tained whether this fraction has a positive effect on the 
translation of RLV-RNA as well. 
From our results the conclusion seems to be justi­
fied that m the cell-free system o(E. coli under the 
direction of the different viral RNA preparations 
tested at least some virus-specific polypeptides are 
synthesized. No specific polypeptides, however, are 
synthesized when this cell-free system is programmed 
with eukaryotic mRNA's. 
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SUMMARY 
A dialyzable factor has been isolated both from the crude 0.5 M KCl 
wash of reticulocytes' and Krebs II Ascites tumor polyribosomes. This 
component is not only required for the in vitro translation of diffe-
rent eukaryotlc messengers like globin and lens crystal lin mRNA, but 
also for the translation of polio and adeno viral RNA. 
INTRODUCTION 
Recently Bogdanovsky et al (1) Isolated a dialyzable factor from the 
0.5 M KCl wash of reticulocyte ribosomes, which restores the activity 
of dialyzed crude initiation factors. The assays were performed in a 
reticulocyte cell-free system. The authors suggested that the dia-
lyzable component was a new RNA species of very small size. 
We have recently shown (2) that, whatever the nature of this factor 
might be, its activity is rather unspecific in that it stimulates the 
translation of globin and lens crystallin messenger RNA in a variety 
of cell-free heterologous systems. 
In the present paper we demonstrate that also viral messengers require 
the factor for translation in vitro. Moreover, we isolated a dialyzable 
component with similar activity as the reticulocyte factor from the 
0.5 M KCl wash derived from polysomes of Krebs II Ascites tumor cells. 
To whom requests for reprints should be addressed 
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MATERIALS AND METHODS 
The Isolation of the dialyzable factor from reticulocytes, the preparation 
of RNAse ribosomes and Krebs II pH 5 enzymes were performed as described 
previously (2). The dialyzable factor from Krebs II Ascites cells was 
isolated in a similar way as reported for the reticulocyte factor. An 
amount corresponding to 450 AjgQ units of polyribosomes was treated 
with 0.5 M KCl at 0° for 2 h. The ribosomes jere spun by centrifugati'on 
at 105,000 χ g for 3 h and the crude initiation factors (26 mg/ml protein) 
were dialyzed for 5 h against 10 vol unes of distilled water. The dialysate 
was lyophilized and resuspended in one quarter of the original volume of 
the crude Initiation factor preparation. 
Cell-free protein synthesis was performed at 30° for 1 h. The reaction 
mixture contained per ml: 10 A 2 6 0 units of RNAse ribosomes from reticu­
locytes, 0.3 mg of pH 5 enzymes, 40 wg mRNA, 100 rnfl KCl, 2 mM MgAc2, 
1 mM DTT, 10 M Trls-HCl pH 7.4, either 3 mg of crude Initiation factors 
or 2 mg of dialyzed Initiation factors and 40 μΤ of the dialyzable 
-factor. The'ATP-generating system and amino acid mixture were as described 
earlier (2). The final volume was 25 μΐ. 
Electrophoresis was performed on SDS slab gels according to Laemli (3). 
However, a linear gel gradient from 6-18Î Polyacrylamide was used and 
the autoradiographic analysis was performed as described elsewhere (4). 
Polio virus (Strain Mahoney type I) was grown in primary monkey kidney 
cells on microcarriers (5) and purified as described by Van Wezel (6). 
RNA was extracted from purified polio virus with SDS-acetate buffer 
pH 3.5 (7). This RNA was further purified by centrifugation through a 
15-30Ï glycerol density gradient, containing 10 mM Tris-HCl pH 7.4, 
100 mM NaCl, 1 n« EDTA.for 4.5 h at 180,000 χ g. 
Adeno-RNA was extracted from KB-cells 35 h after Infection with adeno­
virus type 5 (Strain Ad 75) (8). Crystallin mRNA was isolated as des­
cribed earlier (4). 
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RESULTS AND DISCUSSION 
In an earlier paper we demonstrated the unspecificity of a dialyzable 
factor from the 0.5 M KCl wash, prepared from reticulocyte polyribosomes, 
in stimulating messenger RNA translation in vitro (2). 
However, since exclusively globin and crystallin messengers were utilized 
in our assay systems, the possibility that the factor exhibits its 
activity only towards a limited number of rather small messengers could not 
be excluded. Therefore we investigated the effect of the factor on the 
translation of two messengers derived from virus: one an RNA virus 
(polio), the other a DMA virus (adeno). 
Cell-free protein synthesis was performed under optimal ionic conditions, 
namely 100 mM KCl and 2 mM MgAc2. These optine deviate slightly from 
the optima for the translation of globin and crystallin mRNA (120 mM 
KCl and 2.4 mM MgAc2, respectively) Í2). 
In Fig. 1 it is clearly shown that the translation of the two viral 
messenger species tested is dependent upon the addition of the dialyzable 
factor (IE and IH). As far as the synthesis of the high molecular weight 
proteins is concerned (above 80,000 daltons), the stimulation is con-
siderably higher with the crude KCl wash than with the reconstituted 
dialyzed KCl wash (compare Fig. IF with IH). This holds true for both 
polio and adeno viral messengers. It cannot be excluded that this is 
due to a loss of some componenti s) upon dialysis of the crude KCl wash. 
We observed that dialysis of the initiation factors always causes a 
small precipitate of protein which cannot be redissolved. The translation 
of the globin and crystallin messengers, however, (Fig. IL) is virtually 
unaffected upon recombination of dialyzed initiation factors and the 
dialyzable component. An active dialyzable factor could also be obtained 
from Krebs II Ascites KCl wash. Its stimulating activity on the trans-
lation of viral and crystallin mRNA was identical to that derived from 
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1. Autoradiography of the SUS gel pattern of products synthesized in vitro 
under direction of viral and crystallin messengers in a heterologous 
system. Incubations were performed as described in the Methods section. 
Incubation 
A. minus initiation factors 
B. with crude initiation factors, without added messenger 
С with crude initiation factors and polio mRNA 
D. with dialyzed initiation factors and polio mRNA 
E. with dialyzed initiation factors, polio mRNA and the dialyzable factor 
F. with crude initiation factors and adeno mRNA 
G. with dialyzed initiation factors and adeno mRNA 
H. with dialyzed initiation factors, adeno mRNA and the dialyzable factor 
I. stained control gel (adeno proteins) 
J. with crude initiation factors and crystallin mRNA 
K. with dialyzed initiation factors and crystallin mRNA 
L. with dialyzed initiation factors, crystallin mRNA and the dialyzable factor. 
On gel A and D the amount of protein synthesized is below detection level. 
g · globin 
с = crystallin 
reticulocytes (fig. 2)(only shown for polio mRNA translation). 
We stressed earlier that the RNA nature of the factor proposed by 
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Fig. 2. Autoradiography of the SDS gel analysis of products synthesized in vitro 
in the presence of either crude reticulocyte KCl wash or dialyzed wash 
and the dialyzable factor from Krebs II Ascites tumor cells. 
A. control minus mRNA, with crude initiation factors 
B. incubation with crude initiation factors and polio mRNA 
C. incubation with dialyzed initiation factors and polio mRNA 
0. incubation with dialyzed initiation factors, polio mRNA and the dialyzable 
factor from reticulocytes 
E. incubation with dialyzed initiation factors, polio mRNA and the dialyzable 
factor from Krebs II Ascites tumor cells. 
Bogdanovsky et al (1) is at least questionable (2). We observed that 
the activity of the factor was affected neither by alkali (0.3 N 
KOH at 37° for 15 h), nor by pancreatic RNAse treatment nor by 
heating for 5 min at 100°. In this connexion it has to be mentioned 
that Fuhr and Natta (9) could not detect any loss of activity of a 
presumptive small RNA species isolated from reticulocytes from 
patients with ^-thalassemia upon treatment with RNAse A. 
We separated the factor from KCl by gel filtration on a Sephadex G25 
f i n e column. Furthermore we observed that the factor was not retained 
on a polystyrene column, and that 1t appeared to be soluble i n ethanol 
but could not be extracted with ether. This excludes the p o s s i b i l i t y 
that the dialyzable factor is a l i p i d . 
In a l l of our experiments only st imulat ion but no I n h i b i t i o n of 
heterologous messenger t r a n s l a t i o n has been found. Therefore i t is 
not very l i k e l y that the f a c t o r is ident ica l to the so-called tcRNA 
( t r a n s l a t i o n control RNA) described by Heywood et al (10). The l a t t e r 
authors isolated the a c t i v i t y from a p u r i f i e d I F , preparation and 
found only a negative control o f t r a n s l a t i o n of fteterologous mRNA. 
The e luc idat ion of the real nature of the respective factors awaits 
fur ther i n v e s t i g a t i o n . 
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SUMMARY 
The polyamines spermidine and spermine can replace the dialyzable 
component, previously indicated as "iRNA", in restorinn the acti­
vity of dialyzed initiation factors on nessenqer RNA translation 
in \>.ило. These results further sustain our earlier suggestions 
(1, 2) that the RNA nature of the dialyzable component (3) is 
questionable. 
INTRODUCTION 
Several reports describe the effect of a dialyzable component isolated 
from the 0.5 M KCl wash of reticulocyte ribosomes, which restores the 
activity of dialyzed crude initiation factors (1, 2, 3). While we were 
able to show that this factor was apparently imspecific in its action 
with regard to messenger translation ¿n viVw (1, 2), Heyv/ood et al (4) 
described a dialyzable component (called translational control RNA 
(tcRNA)) fron an initiation factor preparation (IF,) of embryonic chick 
muscle cells. According to the latter authors their factor exhibited 
specificity in that it inhibits the translation of heterolooous mRNA. 
In connexion with reports in the literature (5, 6, 7) dealing with the 
aspecific stimulatory activity of polyamines in cell-free protein bio-
synthesis, we Investigated whether or not spermine and spermidine could 
replace our dialyzable component. In the present report it is shown 
To whom requests for reprints should be addressed. 
"iRNA" « dialyzable factor 
tcRNA = translational control RNA 
IF, * initiation factor 3 
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that these polyamines indeed have the capacity to restore the a c t i v i t y 
of dialyzed i n i t i a t i o n f a c t o r s . 
tIATERIALS AND METHODS 
The i s o l a t i o n of the dialyzable component from rabbi t r e t i c u l o c y t e s , and 
the preparation of RNase treated ribosomes and Krebs I I pH5 enzymes has 
been described previously ( 1 , Z). Cel l - f ree protein synthesis was per­
formed at 30oC f o r 1 h. 
The reaction mixture contained per ml: 10 A , , , uni ts of RNase treated 
ribosomes from r a b b i t r e t i c u l o c y t e s , 0.3mg of Krebs I I pH 5 enzymes, 
40 yq QfJfins 10-14S mRNA, 100 mfl KCl, 1 mM OTT, 10 nfl Tris-HCl, pH 7.4, 
40 wCi[ 3 'S]-methionine ( s p e c i f i c a c t i v i t y ± 200 Ci/mmol), and 3 mg of 
crude i n i t i a t i o n factors e i t h e r without or supplemented with 0.25 mM 
spermidine or spermine. The dialyzed i n i t i a t i o n factors in contrast to 
the crude factors required 1 mM spermidine or spermine f o r optimal s t i ­
mulation. The optimal MgAc- concentration was 2 mfl in the presence of 
polyamines or 3 mM without polyamines. The ATP generating system and 
amino acid mixture were as described e a r l i e r ( 2 ) . The f i n a l reaction 
mixture was 25 μ ΐ . 
The polypeptides synthesized tie now in the c e l l - f r e e system were ana­
lyzed by electrophoresis on 7-18% Polyacrylamide gradient slab oels i n 
the Tr is-glyc ine buf fer system ( 8 ) . After the electrophoret ic run the 
gels were treated wi th Me^ SO-PPO (9) and dried down on f i l t e r paper be­
fore s c i n t i l l a t i o n autorafliography. 
RESULTS AND DISCUSSION 
Although Bogdanovsky et al (3) suggested that the dialyzable component 
from the 0.5 M KCl wash of ret icu locyte ribosomes was a small RNA spe­
c i e s , our previous resul ts ( 1 , 2) were not in favor of th is assumption. 
F i r s t l y : The dialyzable component could not be precip i tated with etha­
nol even in the presence of c a r r i e r RNA, i t s a c t i v i t y was completely 
recovered from the ethanol layer ( 2 ) . Secondly: Treatment with a l k a l i 
or pancreatic RNase did not destroy the a c t i v i t y of the dialyzable 
component. Likewise the factor resisted heating f o r 5 mn at 100 С ( 1 , 
2 ) . T h i r d l y : A polystyrene column, which normally binds nucleotides, 
did not r e t a i n the dialyzable a c t i v i t y ( 1 ) . 
Another discrepancy between our results and the f i r s t observation of 
Bogdanovsky et al (3) concerned the molecular weinht of the conponent. 
Whereas a molecular weight of approximately 10,000 was reported 
ITT = 1 , 4 - d i t h i o p r y t h r e i t o l 
РР0 = 2,5-diphenyloxazol 
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Figure 1 
Γ 3 5 Ί Autoradiography of the SDS Polyacrylamide gel electrophoresis of _ Sj-
methionine-labeled products of cell-free protein synthesis. 
Two microliters of the incubation [fixtures described in the Materials 
and Methods section were used for each sanple. The X-ray film was expo­
sed in contact with the dried gel for 2 days. 
The reaction mixtures vere supplemented with: 
A) crude reticulocyte initiation factors, 3 nM MnAc,; no added mRNA 
B) crude initiation factors, 3 nil MqAc- and 10-14S Tens mRNA 
C) crude initiation factors, 2 mM MgAcj, 0.25 mfl spermidine; no added nRNA 
D) crude initiation factors, 2 mM MgAc?, 0.25 иН spermidine and 10-14S 
lens mRNA 
E) dialyzed initiation factors, 3 mM MgAc-; no added mRNA 
F) dialyzed initiation factors, 3 mM MgAcj and 10-14S lens mRNA 
G) dialyzed initiation factors, 2 mM MgAcj, 1 mM spermidine; no added mRNA 
H) dialyzed initiation factors, 2 mM MgAc«, 1 mM spermidine and 10-145 
lens mRNA 
by the former authors, in our experiments, using Sephadex G10 and G15 
gel filtration columns, the activity was localized in the 300-600 dal-
tons region. 
SDS = NaDodSO 
E F G Η 
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Since the molecular weight of the unidentified component was relatively 
low, and in view of reports in the literature stating that polyamines 
can stimulate aspecifically cell-free amino acid incorporation, we veri-
fied if the dialyzable component could be replaced by one or more of 
these polyamines. 
F1g 1 shows the effect of spermidine on lens messenger translation -ui 
vitAo. Spermine has a similar effect (not shown) It can clearly be seen 
that 1 mM spermidine restores the activity of the dialyzed initiation 
factors to an extent comparable with the activity of the undialyzed crude 
initiation factor preparation (Figs IH and IB) Albeit also crude ini-
tiation factors are slightly stimulated by spermidine (Fias. IB and ID), 
this occurs at a considerable lower concentration (0 25 mM) of the poly-
amines These experiments clearly demonstrate that the polyamines have 
a similar effect as the dialyzable component described previously (1). 
Even in greater detail the similarity in effects of the dialyzable 
component and polyamines is striking. The high molecular weight poly-
peptides are less efficiently synthesized in the presence of the dia-
lyzed initiation factors recombined with the dialyzable component than 
with crude initiation factors. The same holds true when the dialyzed 
initiation factors are "recombined' with the polyamines 
Since the yield of the dialyzable component is extremely low and batch-
wise preparation is not feasable due to decrease of activity upon sto-
rage, up till now a definite identification is seriously hampered 
Nevertheless there are no obvious arguments against the assumption 
that the real nature of the aspecific dialyzable component, previously 
designated as "iRNA", is that of a polyamine Even the observed loss 
of activity upon storage is in striking accordance with the strongly 
decreased activity of the polyamines due to oxidation 
The present studies add some new data to the already known biochemical 
effects of the polyamines spermidine and snermine in protein synthesis (10). 
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Summary 
Rauscher leukemia virus RNA (RLV RNA) is translated in mammalian cell-
free systems into distinct polypeptides which are immunoprecipitable by an 
antiserum directed against RLV protems. These polypeptides partially comi-
grate electrophoretically with native viral proteins synthesized in vivo in JLS-
V9 cells. Besides 72 000-, 65 000- and 50 000-dalton polypeptides a 15 000-
dalton polypeptide is also synthesized in vitro Analysis of incubations of RLV 
RNA m different cell-free systems reveals that no virus-specific factors are 
required in the translation of RLV RNA in vitro. 
Introduction 
In a previous paper we reported that the addition of oncogenic viral RNA to 
a cell-free system, derived from Escherichia coll, resulted in a number of virus-
specific translation products, most of them in the low molecular weight range 
The newly synthesized polypeptides were detectable by means of autoradiogra­
phy after sodium dodecyl sulphate electrophoretic separation [1]. However, 
we were not able to detect virus-specific polypeptides by incubating Rauscher 
leukemia virus RNA in a reticulocyte lysate. 
Meanwhile, several papers appeared m the literature reporting the synthesis 
of virus-specific polypeptides directed by oncogenic viral RNA in mammalian 
cell-free systems and demonstrated by means of immunoprecipitation For in­
stance Rous sarcoma virus RNA (RSV RNA) was translated m Krebs Ascites 
cell-free systems into a 75 000—80 000-dalton polypeptide which shared com­
mon ведцепсез with authentic virion group-specific protems [2]. On the other 
* To whom reque*ts for lepilnU shcrald b« addniMil 
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hand RLV RNA seemed to direct the synthesis of at least two classes of 
polypeptides of 50 000-75 000 daltons and of 140 000—185 000 daltons, re­
spectively, in a cell-free system denved from JLS-V5 cells [3]. In view of these 
observations, we reinvestigated the translation of RLV RNA in a number of 
heterologous cell-free systems and found that (a) in all systems tested, similar 
products precipitatale with antiserum directed against RLV are synthesized and 
(b) that both high molecular weight polypeptides (72 000 and 65 000 daltons) 
and smaller species (15 000—30 000 daltons) can be detected. 
Materials and Methods 
Cell cultures 
Krebs II Ascites tumor cells were propagated by sena] transplantation intra-
pentoneally in BIO D2 mice [4]. JLS-V9 cells, derived from bone marrow cells 
of Balb/c mice [5] and productively infected with RLV were grown as mono­
layers [6]. Rabbit reticulocytes were prepared as described previously [7]. 
Purification of RLV RNA 
RLV was obtained from the plasma of leukemic Swiss mice [8] and treated 
with sodium dodecyl sulphate and pronase The 60-S component of the RLV 
RNA was isolated by centrifugation in isokinetic glycerol gradients (15—30%, 
w/v) [6]. The isolated 60-S RLV RNA was denatured by heating at 100oC for 
3 mm. 
Synthesis of virus-specific DNA probes 
High specific-activity radioactively-labeled DNA, complementary to RLV 
RNA (RLV-cDNA) was synthesized using the viron RNA-directed DNA poly­
merase [6]. 
Nucleic acid hybridization 
The relative amount of virus-specific RNA present in the vanous glycerol 
gradient fractions was determined by annealing the different fractions with 
RLV cDNA according to Berns et al. [9]. 
Cell-free protein synthesizing systems 
The preparation of cell-free extracts from the cells mentioned above, the 
isolation of washed RNAase-treated nbosomes, pH 5 enzymes and 100 000 X g 
supernatant (S-100 fraction) from these extracts, and the conditions for pro­
tein synthesis were as described previously [10]. 
A typical m vitro incubation contained per ml: 20 mM Tris · HCl pH 7.4, 
100 mM Κα, 2mM MgOAc2, 5 Л г 4 0 п г а units of nbosomes, 260 /jg S-100 
fraction of pH 5 enzymes, 3 mg of crude initiation factor protein, 40 μg 
mRNA, 1 mM ATP, 0.2 mM GTP, 10 mM creatinephosphate, 100 /ig creatine-
phosphate kinase, 2 mM 2-mercaptoethanol, 19 amino acids at 50—100 μΜ 40 
μΟ of f3 s S] methionine (specific activity ± 200 Ci/mmol). The reaction mix­
tures final volume 25 μΐ were incubated at 30° С for 60 mm. . Trichloroacetic 
acid-precipitable radioactivity was determined from a 2-μ1 aliquot. Another 2-μ1 
aliquot was analyzed by sodium dodecyl sulphate gel electrophoresis (see be-
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low) and the remaining 21-μ1 incubation mixture was precipitated by anti­
serum against RLV (see below). 
Immunoprecipitation 
The RLV-specific polypeptides synthesized in the heterologous cell-free sys­
tems were detected by direct and indirect immunoprecipitation as described by 
Van Zaane et al. [11]. 
Product analysis 
Analysis of the cell-free products on sodium dodecyl sulphate/polyacryl-
amide slab gel gradients was performed according to Berns et al. [10]. Slab gels 
were treated with dimethylsulphoxide-2,5-diphenyloxazol [12] and dried 
down on filter paper before scintillation autoradiography. 
Results 
In vitro translation of RLV RNA 
The results of a typical translation experiment in a heterologous cell-free 
system are summarized in Table I. 
Addition of denatured (30—40 S) RLV RNA to heterologous cell-free sys­
tems generally results in an approx. 4-fold stimulation of the amino acid incor­
poration in vitro as compared with native (60 S) RLV RNA that gives only a 
2-fold stimulation over the background of control incubations, containing no 
RNA. The optimal magnesium and potassium concentrations were 2 mM and 
100 mM, respectively. Incorporation of [ 3 s S] methionine was linear for about 
40 min (not shown). 
The results summarized in Table I also show that only polypeptides synthe­
sized in response to RLV RNA are immunoprecipitable. However, only 4—5% 
of the trichloroacetic acid-precipitable [3 5S]methionine counts incorporated 
above the background radioactivity were precipitable. This may be due to the 
stimulation of the endogenous system after addition of RLV RNA (compare 
Fig. 1, 7 and 9). Another possible reason for the rather low amount of precipi-
TABLEI 
STIMULATION AND IMMUNOPRECIPITATION OF THE [ 3 sS]METHIONINE INCORPORATED BY 
EXOGENOUS mRNA IN A HETEROLOGOUS CELL-FREE SYSTEM 
The reaction mixture contained In a final volume of 2b μΐ: 1 μκ of mRNA, 1 μα [ 3 5S]metlilonlne. 
waahed reticulocyte RNAie-treated rlbosomef. crude reticulocyte Initiation faeton and JLS- S-100 
fraction. Incubation wa· for 1 Ь at 30° С immunoprecipitation waa as described in the Materials and 
Metbods section. 
RNA added [ 3 sS]methlonlne Incorporated in Anti-RLV 
trichloroacetic acid precipitatale precipitable 
(cpm) (cpm) 
none 48 750 M 
10-S lens mRNA 360 490 84 
«O-S RLV RNA 87 4BO 2063 
30—40S RLV RNA 186 060 444» 
72,000 
65,000. 
15,000 
8 9 Ю 11 12 13 14 15 16 17 18 19 
ст. 
Flg. 1. Sodium dodecyl sulphate Bel electrophoresis of polypeptides synthesized in vitro in a cell-free system containing washed reticulocyte RN Aase ribosomes, 
crude reticulocyte initiation factors and different enzyme systems in the presence or absence of either 1 Mg 10-S crystallin lens mRNA or 1 μί 30—40-S RLV RNA 
(final volume 25 μΐ) The X-ray film was exposed in contact with the dried gel for 3 days. Incubation with: (1) reticulocyte pH 5 enzymes without mRNA; (2) reti­
culocyte pH & enzymes with 10-S lens mRNA; (3) reticulocyte pH & enzymes with RLV RNA; (4) JLS-V9 pH Ь enzymes without mRNA; (5) JLS-V9 pH & en­
zymes with 10-S lens mRNA; (6) JLS-V9 pH 5 enzymes with RLV RNA; (7) Krebs Π pH 5 enzymes without mRNA; (8) Krebs II pH 5 enzymes with 10-S lens 
mRNA; (9) Krebs II pH 5 enzymes with RLV RNA; (10) reticulocyte S-100 fraction without mRNA; (11) reticulocyte S-100 fraction with 10-S lens mRNA; (12) 
reticulocyte S-100 fraction with RLV RNA; (13) JLS-V9 S-100 fraction without mRNA; (14) JLS-V9 S-100 fraction with 10-S lens mRNA; (15) JLS-V9 S-100 
traction with RLV RNA; (16) Krebs II S-100 fraction without mRNA; (17) Krebs II S-100 fraction with 10-S lens mRNA; (18) Krebs II S-100 fraction with RLV 
RNA; (19) JLS-V9 S-100 fraction with RLV RNA and 5-adenosylmethionine. 
table radioactivity might be the lack of antigenicity of a number of de novo 
synthesized RLV-specific polypeptides, since it cannot be ruled out that post-
translational modifications (i.e. glycosylation) did not take place or that prema­
ture termination leads to non-antigenic RLV polypeptides. 
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Pig. 2. Sodium dodecyl sulphate gel electrophoresis of immunoprecipitated polypeptides synthesized in 
vitro in cell-free systems м dMCtibcd in Fig. 1, For comparison, viral proteins synthesized in vivo in 
JLS-V9 cells are also included. ІЪе X-ray fílm was exposed in contact with the dried gel for 3 days. 
Immunoprecipitation of: (1) viral proteins labeled in vivo in JLS-V9 cells; (2) incubation with JLS-V9 
S-100 fraction, denatured RLV RNA and S-adenosylmethionine; (3) incubation with Krebs II S-100 
fraction and denatured RLV RNA; (4) incubation with Krebs II S-100 fraction and 10-S lens mRNA; (5) 
Incubation with JLS-V9 3-100 fraction and denatured RLV RNA; (6) incubation with JLS-V9 S-100 
fraction and 10-S lens mRNA; (7) incubation with reticulocyte S-100 fraction and denatured RLV RNA; 
(8) incubation with reticulocyte S-100 fraction and 10-S lens mRNA; (9) incubation with Krebs pH & 
«nzymes and denatured RLV RNA; (10) incubation with Krebs pH Ь enzymes and 10-S lens mRNA; (11) 
incubation with JL.S- Э pH & enzymes and denatured RLV RNA; (12) incubation with JLS-V9 pH 5 
enzymes and 10-S lens mRNA; (13) incubation with reticulocyte pH 6 enzymes and denatured RLV 
RNA; (14) incubation with reticulocyte ρII 5 enzymes and 10-S lens mRNA. 
fid 
Analysis of the products 
The [3sS]methionine-labeled products, synthesized in vitro in different 
cell-free systems under direction of denatured RLV RNA, were analyzed on 
sodium dodecyl sulphate/polyacrylamide slab gels. The migration patterns are 
depicted in Fig. 1. The cell-free systems containing the S-100 fraction and RLV 
RNA (Fig. 1, 12, 15, 18 and 19) obviously synthesize polypeptides in the 
molecular weight range of 12 000—72 000 which are absent in control gels of 
incubations supplemented with lens crystallin 10-S mRNA (Fig. 1, 11, 14 and 
17) or without any mRNA (Fig. 1, 10, 13 and 16). The heterologous systems 
supplemented with pH 5 enzymes instead of S-100 fraction reveal less clearly 
the synthesis of these virus-specific products (Fig. 1,1—9). Therefore the incu­
bations were subjected to immunoprecipitation with antiserum prepared 
against RLV (Fig. 2). For comparison the pattern of virus-specific polypeptides 
synthesized in vivo in JLS-V9 cells is included (Fig. 2, 1). All the systems 
tested, except the reticulocyte/pH 5 system, unequivocally contain 15 000-, 
50 000-, 65 000- and 72 000-dalton polypeptides. The predominant 82 000-
dalton precursor present in JLS-V9 cells in vivo [11] is not synthesized in these 
in vitro incubations, while the 15 000-, 50 000- and 65 000-dalton polypep­
tides are present both in vivo and in vitro. Cell-free incubations with added 
pH 5 enzymes contain more low molecular weight products than incubations 
with the different S-100 fractions (compare Fig. 2, 1—8 with Fig. 2, 9—14). 
Incubations with S-adenosylmethionine that donates methyl groups to the 5' 
end of viral mRNA [13,14] did not enhance the synthesis of virus-specific 
polypeptides (compare Fig. 1, 15 and 19 and Fig. 2, 2 and 5). Immunoprecipi­
tation of incubations supplemented with crystallin 10-S RNA or without any 
messenger was always negative (Fig. 2, 4, 6 and 8 etc.). 
In order to determine which RNA species within the virion was responsible 
for the synthesis of different virus-specific proteins, native 60-S RLV RNA was 
DNA hybridyzed (%) , 
50 η 185 2β& 355 
1 1 i 
40-) 
30 У \ 
20- / \ 
10- / tí 
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Flg. Э. Native βΟ-S RLV RNA w o detutured by beating ш redntiDed water for 3 min at 100° С and 
rapidly cooled. The heat-denatured RLV RNA wai then analyzed on a lb—30% (w/v) bokioctic glycerol 
gradient Fnctiona of 0.8 ml were collected and ptecipitated with ethanol alter addition of 20 jig 
•eticulocyte 28-5 RNA aa a carrier. The relative amount of vinii ipecffie RNA waa determined by hybridi­
zation with RLV с DNA. 
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heat-denatured and centrifuged in an isokinetic glycerol gradient [6]. The gra­
dient was divided into 14 fractions of which each was assayed for mRNA 
activity in a heterologous cell-free system. 
Each fraction was hybridized with RLV-cDNA for the detection of virus-
specific RNA sequences in the different gradient fractions (Fig. 3). Both native 
and denatured RLV RNA hybridizes up to 96% with the cDNA. In our experi­
ments hybridization was carried out to a 35% level in order to visualize the 
relative amount of the individual viral messengers. There is a lineair relationship 
only between the percentage of hybridized and relative RNA concentration for 
hybridization values of less than 50%. Equal amounts of RNA have been taken 
1 2 3 4 5 6 7 8 9 10 11 12 13 Ί 4 
Fig. 4. Sodium dodecyl sulfate gel electrophoresis of polypeptides synthesized In vitro under direction of 
the different RNA fractions obtained from the gradient In Fig. 3 in a cell-free system containing washed 
reticulocyte RNAase ribosomes. crude reticulocyte initiation factors and Krebs Ascites pH 5 enzymes. 
The X-ray film was exposed In contact with the dried gel for 4 days. 
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Pit. 6. Sodium dodecyl sulfate electrophoresis of immunoprecipitated polypeptides synthesized in vitro as described in Fig. 4. For comparison viral proteins syn-
thesized in vivo in JLS-V9 cells and [3 sSlmethionine-lsbeled RLV were also analyzed. The X-r»y film was exposed in contact with the dried gel for 4 days. 
ImmunoprecipiUtions of the incubations described in Fig. 4: gels 1—14; Immunoprecipitations of tlje incubations with 10-S lens mRNA or without RNA: gels 
IS—16; Viral proteins labeled In vivo in JLS-V9 cells; gel 17; [3sS]methionlne-lsbeled RLV proteins: gel 18. 
from the gradient to serve as messengers in the heterologous cell-free systems. 
The products synthesized were either analyzed directly on sodium dodecyl 
sulphate gels (Fig. 4) or assayed after immunoprecipitation (Fig. 5). The low 
molecular weight RNA fractions only stimulate the synthesis of small polypep­
tides (Fig. 4, 2, 3) while the 30—40-S RNA enhance the synthesis of poly­
peptides in the molecular weight range from 30 000—72 000 (Fig. 4, 5—9). 
Indirect immunoprecipitation of the incubation mixtures clearly demonstrates 
that the 72 000- and 65 000-dalton polypeptides are predominantly synthe­
sized under direction of the 30—40-S RNA fraction while the 15 000- and 
50 000 dalton-products are synthesized under direction of RLV RNA of about 
18 S. For comparison, RLV proteins synthesized in vivo in JLS-V9 cells and 
KU- β; Sodium dodecyl lulfate gel electrophoresis of polypeptides synthesized in vitro under direction of 
(1) 2 μκ heat-denatured 30- 40-S or (2) 2 μκ native 60-S RLV RNA in a cell-free system containing 
washed reticulocyte RNAase ribosomes, crude reticulocyte initiation factors and reticulocyte S-100 frac­
tion (final volume 25 μΐ). Sodium dodecyl sulfate gel analysis of the inununoprecipitable polypeptides 
synthesized as described above under direction of (3) heat-denatured 30—40-S or (4) native 60-S RLV 
RNA. In both cases the X-ray film was exposed in contact with with dried gel for 2 days. 
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[35S]methionine-labeled RLV proteins aie also shown (Fig. 5). It should be 
noted that native 60-S RLV RNA only slightly stimulates the synthesis of the 
72 000-dalton component as compared to heat-denatured RLV RNA (Fig. 6,1 
and 2). Using reticulocyte S-100 fraction as a source of enzymes a small 
amount of polypeptides up to 120 000 daltons is synthesized (Fig. 6, 3 and 4). 
Discussion 
Our present experiments show that RLV RNA is translated in several cell-
free systems into distinct polypeptides which are immunoprecipitable by anti-
serum directed against RLV. The anti-RLV serum precipitates 50—60% of the 
soluble viral proteins present in isolated Rauscher leukemia virions. As was 
shown by Van Zaane et al. [11] all the major virion polypeptides except plO 
and pl2 were precipitated equally well by this anti-RLV serum. As far as the 
specificity of the immunoprecipitation is concerned it has clearly been demon-
strated in Table I that only after addition of RLV RNA to a heterologous 
cell-free system polypeptides synthesized de novo can be precipitated. The 
labeled lens crystallin polypeptides synthesized after programming the cell-free 
system with 10-S lens mRNA are not precipitable at all with the anti-RLV 
serum. 
Aspecific immunoprecipitation was further excluded by experiments in 
which incubation mixtures programmed with RLV RNA or lens 10-S mRNA 
and supplemented with bovine serum albumine were immunoprecipitated with 
antd-bovine serum albumin serum. Those precipitates did not contain any radio-
active components. In the JLS-V9 cell line, infected with RLV, two large 
membrane-associated virus-specific polypeptides with molecular weights of 
82 000 and 65 000 are synthesized. The 65 000-dalton polypeptide is con-
verted into the virion proteins p30, pl5 and pl2; the 82 000-dalton polypep-
tide is glycosylated and is probably the precursor of glycoprotein 69/71 [11]. 
In vitro, however, in a number of mammalian cell-free systems the main 
products synthesized are polypeptides with molecular weights of 72 000, 
65 000 and 15 000 (compare Fig. 2). The last-named polypeptide is also made 
in a cell-free system derived from E. coli as has been described previously [1]. 
As has been shown by means of hybridization techniques [6,15,16] synthesis 
of virus-specific polypeptides proceeds in association with membranes. More-
over, Gielkens et al. (see réf. 20) have found that polyribosomes still attached 
to membranes (i.e. rough membranes from JLS-V9 cells) synthesize polypep-
tides in vitro with molecular weights of 65 000 and 82 000, respectively. How-
ever, poly Α-rich 35-S RNA isolated from these polyribosomes directs the 
synthesis of virus-specific polypeptides with molecular weights of 65 000 and 
72 000, respectively. The same polypeptides are detectable after incubation of 
virion 35-S RNA in mammalian cell-free systems (compare Fig. 2). Therefore 
one may speculate that in the in vitro systems the 72 000-dalton rather than 
the 82 000-dalton polypeptide is synthesized, because the cell-free systems lack 
the cell membrane fractions essential for posttranslational glycosylation. 
Another possibility is the existence of an interrelationship between the 
65 000- and 72 000-dalton polypeptides. In that case it has to be explained 
why the 82 000-dalton polypeptide is not found in the in vitro incubations. As 
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stated above the glycosylated 82 000-dalton polypeptide is probably synthe­
sized in vitro as a non-glycosylated protein. It is conceivable that this non-
glycosylated protein is less antigenic than the glycosylated 82 000-dalton poly­
peptide and therefore not detectable by the immunoprecipitation procedure. 
Denaturation of 60-S RLV RNA results in the appearance of a number of 
different RNA species (Fig. 3). In addition to 35-S RNA, size-classes between 
14 S and 35 S are also present. Aggregation of the different size classes is 
unlikely, since a similar RNA profile is obtained under denaturing conditions in 
50% formamide. Moreover, the same classes of RNA species have also been 
found in polyribosomes infected with RSV [17], RLV [6] and in mouse cells 
infected with Moloney murine leukemia virus [18]. Furthermore, immature 
RSV contains in addition to 60-S RNA a rather heterogenous population of 
RNA species sedimenting between 14 S and 35 S [19]. Our results indicate 
that some of the smaller species can code for discrete low molecular weight 
viral polypeptides, whereas the fractions between 28 S and 35 S code at least 
for virus polypeptides up to 72 000 daltons. Anyway, all our observations 
strongly suggest that one of the primary translation products of 35-S RLV 
RNA is a 72 000-dalton polypeptide which undergoes post-translational modifi­
cations. 
The translation of RSV RNA in a Krebs Ascites cell-free system reported by 
others [2] is in accordance with our results. In the latter, cell-free system 
polypeptides with approximate molecular weights of 75 000—80 000 sharing 
common sequences with the group-specific proteins of the virion are synthe­
sized. Moreover, it has been stated that heat-denatured RSV RNA is a better 
template for polypeptide synthesis in vitro than native RNA. This observation 
also agrees with и\е results presented here and our earlier findings in the E. coli 
cell-free system [ 1 ] . Analysis of the products directed by RLV RNA in the 
different cell-free systems and the finding that in the cell-free systems supple­
mented with S-100 fraction from RLV-infected JLS-V9 cells, the same set of 
virus-specific polypeptides are synthesized with the same efficiency, leads to 
the conclusion that apparently no virus-specific factors are involved in the 
translation of this RNA (Fig. 1, 2). It should be noted, however, that a larger 
amount of low molecular weight products is synthesized in the presence of 
pH 5 enzymes as compared with incubations containing the S-100 fraction. In 
the latter case, small amounts of high molecular weight polypeptides up to 
120 000 are synthesized (Fig. 6) which are immunoprecipitable with anti-RLV 
serum. 
We were not able to demonstrate the synthesis of a RLV precursor polypep­
tide in the range of 140 000—180 000 daltons as has been reported by Naso et 
al. [ 3 ] . Ilie latter authon used a JLS-V5 S-30 cell-free system and only native 
60-$ viral RNA as messenger to direct the synthesis of the 140 000-180 000 
dalton precursors as predominant products. As has been mentioned before, in 
our in vitro systems, native RLV RNA was a rather poor messenger whereas as 
a predominant product a 72 000-dalton polypeptide was synthesized under 
direction of denatured RNA. We do not have an explanation for this discrep­
ancy, especially because in the JLS- Б S-30 system used by Naso et al. [3] 
membranes were probably lacking. Since incubation with S-adenosylmethio-
nine does not enhance the synthesis of virus-specific polypeptides, it is very 
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likely that the viral messengers are, at least at the 5' end, intact, provided it 
holds true that the 5' end of all translatable messenger RNA is methylated' 
[13,14] and the JLS-V9 S-100 fraction contains methylase activity. 
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SUWARY 
AMV-RNA was translated into a precursor polypeptide of 76,000-80,000 
daltons in a reticulocyte cel l - free system. Besides this high mole-
cular weight precursor, several smaller precursor polypeptides and 
the four major internal structural viral proteins were also synthe-
sized. These virus-specific translation products were detectable 
after litminoprecipitation with antiserum against the gs-antigens of 
AMV. 
INTRODUCTION 
Recently Vogt and Eisenman (1) showed, by means of immunopreclpitation, 
that 1n AMV-infected primary chick fibroblasts some of the major struc-
tural proteins of AMV are derived by cleavage from a common precursor 
protein of 76,000 daltons. In further in vivo studies these authors 
identified five metabolically unstable AMV precursor polypeptides (2) . 
The arrangement of the virion proteins in these in vivo precursor poly-
peptides was determined by means of inhibition of polypeptide chain 
In i t iat ion by pactamycin. Meanwhile, several papers appeared in the 
l i terature reporting the cel l - free translation of RSV-RNA (3) and RLV-
RNA (4, 5 ) . Furthermore Ascione et al (6) described a cel l - free mamma-
To whom requests for reprints should be addressed 
Abbreviations : 
AMV ' avian myeloblastosis virus 
gs - group-specific 
RSV = Rous sarcoma virus 
RLV « Rauscher leukemia virus 
OTT = 1,4-dithiothreitol 
SDS = sodium dodecyl sulfate 
PRO = 2,5-diphenyloxazol 
S30 = 30,000 χ g supernatant fraction 
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lian system which upon addition of AMV-RNA was capable to stingiate 
the overall amino ac+d incorporation. However, since no product analysis 
was carried out by the latter authors, no conclusions could be drawn 
concerning the de novo synthesis of AMV-specif1c polypeptides. For this 
reason 1t seemed to be interesting to establish whether or not specific 
viral polypeptides were synthesized in a cell-free system programmed 
with AMV-RNA. 
In the present paper we provide evidence for the in vitro synthesis of 
the same AMV-specific precursor polypeptides and structural proteins 
as have been found in vivo. 
MATERIALS AND METHODS 
Rabbit reticulocytes were prepared as described earlier (7) and lysed 
by addition of water. A 30,000 χ g supernatant fraction of these lysed 
cells was used as cell-free system and incubations were performed at 
30oC for 1 h. 
The reaction mixture contained per ml: 0.6 ml of reticulocyte cell-free 
extract, 20 mM Tris-HCl, pH 7.4, 100 mM KCl, Ζ,-ΐηΜ MgAc,, 0.2 mM spermi­
dine, 2 mM DTT, 40 pg of AMV-RNA and 40 yCi [ " $ -methionine (specific 
activity ± 200 Ci/mmol). The ATP generating system and amino acid fix­
ture were as described by Berns et al (8). The final volume of the in­
cubation mixture was 25 μΐ. 
AMV-RNA was obtained from purified virus which was derived from infected 
chicken plasma (9) and treated with SDS and pronase. The hiah molecular 
weight AMV-RNA was isolated by centrifugation 1n isokinetic glycerol 
gradients (10). The isolated 60S AMV-RNA was denatured by heatina at 
100 С for 3 min. For comparison 60S RLV-RNA was isolated and denatured 
in the same way as described for AMV. The AMV-specific polypeptides 
synthesized in the cell-free system were detected by indirect immunopre-
cipitation (11) with an antiserum prepared by hyperimmunization of a 
rabbit with Nonidet P.40 disrupted AMV in Freund's adjuvant (1). The 
RLV-specific polypeptides synthesized in a reticulocyte cell-free system 
programmed with RLV-RNA were imunoprecipitated with anti-RLV-serum (11). 
10S Lens mRNA, kindly provided by Mr L. Cohen fron our laboratory, was 
translated and treated with anti-AMV-serum to check for aspecific inmuno-
precipitation. 
The products obtained upon immunoprecipitation were analyzed on SDS qel 
gradients (7-18%) according to Berns et al (8). After the electrophoretic 
run the slab gels were treated with Me,S0-PP0 and dried down on filter 
paper before scintillation autoradiography (12). 
RESULTS AND DISCUSSION 
The results of a typical translation experiment of AMV-RNA in a reticu­
locyte cell-free system are shown in Table I. 
Due to the extremely high endogenous globin synthesis of the lysate 
system almost no stimulation of the amino acid incornoration was ob-
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tained either after addition of lens IOS mRNA or of AHV-RNA. However, 
imunoprecipltatlon of the incubation mixtures with anti-AMV-serum re­
vealed that only after programing the reticulocyte lysate with AMV-RNA 
a small amount of radioactivity was preci pi table. 
The specificity of the imunoprecipitation was checked by the following 
experiments: 
1) Control incubations without mRNA or with IOS lens nRNA did not give 
rise to polypeptides which were precipitable with anti-AMV-serum. 
Z) After incubation of AMV-RNA in the reticulocyte system and addition 
of an antiserum directed against a non-related murine leukemia virus 
(anti-RLV-serum) no precipitation of polypeptides occurred. Likewise, 
no precipitable products could be detected upon Incubation of RLV-RNA 
in the lysate followed by addition of an antiserum directed against 
the non-related avian myeloblastosis virus (anti-AMV-serum). 
TABLE I 
|_ Sj-methionine incorporation and imnunoprecipitation of a reticulocyte 
cell-free system prograrmed with mRNA. 
RNA added 
none 
IOS lens mRNA 
denatured AMV-RNA (35S) 
native AMV-RNA (60S) 
S -methionine 
incorporated in 
CCKCOOH-precipitable cpp 
10.8 χ 10 6 
11.2 χ 10 6 
10.1 χ 10 6 
11.1 χ 106 
anti-AMV-serum 
precipitable еря 
30 
56 
1053 
3115 
76 
3) Incubation mixtures programmed with viral or lens mP.NA, supplemented 
with BSA, and immunoprecipitated with anti-BSA-serum did not contain 
~35 " 
any radioactive component. The analysis of the ^ SJ-methionine label­
ed and immunoprecipitable products synthesized under direction of 
native or denatured AMV-RNA are depicted in Fiq. 1. 
60S AMV-RNA (Fig. 1: 1) gives rise to the synthesis of virus-specific 
polypeptides with molecular weights of 80, 76, 66, 50, 32, 25, 18, 14, 
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FIGURE: 1 
Autoradiography of the SDS gel analysis of immunoprecipitable poly­
peptides synthesized in vitro in a reticulocyte cell-free system 
which has been programmed with oncogenic viral RNA. 
Incubations and immunoprecipitations were performed as described in 
the Materials and Methods section. 
The X-ray film was exposed in contact with the dried gel for 3 days. 
Incubation with: 
1) native AMV-RNA 
2) denatured AMV-RNA 
3) native RLV-RNA 
4) denatured RLV-RNA 
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12, and 10 χ 1(Γ. Denatured AMV-RNA (Fiq. 1· 2) leads to the synthesis 
of the polypeptides with molecular weights of 66, 32, 18, and 14 χ 10 . 
In the latter case a much smaller quantity of the high molecular weiqht 
polypeptides was synthesized. 
Native and denatured RLV-RNA give rise to the synthesis of polypeptides 
with molecular weights of 72, 65, and 15 χ 10 beside some smaller poly­
peptides (Fig. 1: 3 and 4) (5). Control inrnunoprecipitations of incuba­
tions proqramned with 10S lens mRNA or without RNA did not reveal any 
bands. 
Our in vitro translations of AMV-RHA are in good agreement with the in 
vivo studies of Vogt et al (2). The latter authors found five unstable 
AHV-specific precursor polypeptides, namely pr76, pr66, pr60, pr32, and 
prl2 in addition to the viral internal structural proteins p28 and pl4 
(where pr stands for precursor polypeptide, ρ for polypeptide present 
in the virion, whereas the number indicates the molecular weight in 
dal tons χ 10" 3). 
By incubating isolated AMV-RNA in a cell-free system we were able to 
demonstrate the synthesis of the same precursor polypeptides (pr76-80, 
pr66, pr32 and prl2) and some additional polypeotides, probably cleavage 
products of these precursors. Furthermore we found the internal structu­
ral proteins p28 (however, 25,000 daltons in our system), plO and pl4 
(in our systems 12,000 and 10,000 daltons, respectively (13)). It is 
striking that, whereas the in vivo and in vitro translation of AMV-RNA 
and processing of the precursor polypeptides in the corresponding pro­
ducts is very similar, the situation with RLV is greatly different (5) 
In the latter case a number of polypeptides synthesized in vivo could 
not be detected in the in vitro experiments. This may be explained by 
one or both of the followinq reasons 
1) The precursor for the qlycoproteins found in vivo ir the PLV system 
(11) is not detectable in vitro (5), whereas such a precursor has 
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not been observed In the in vivo and in vitro system for AMV because 
the anti-AMV-serum is directed only against the gs-antigens. 
2) The enzymic cleavage of the precursors in the AMV system is different 
from that in the Rauscher system. Since we used an S30 fraction, in 
which membranes have been removed, it is possible that a number of 
membrane-bound proteolytic enzymes, responsible for the processing of 
the RLV precursor, are lacking. 
In any case it may be concluded from our results that the enzymes res­
ponsible for the processing of the AMV precursor polypeptides are present 
in the reticulocyte S30 lysate since the same viral precursors and struc­
tural polypeptides which are present in vivo are also synthesized in the 
in vitro system. Furthermore upon prolonged incubation of AMV-RNA in the 
S30 lysate (up to 18 h) the high molecular weight precursors (pr76-80) 
disappear, whereas the amount of structural proteins increases. This 
means that, whereas initiation and elongation continue only for 3-4 h in 
our lysate system, enzymic cleavage continues upon prolonged incubation. 
Nevertheless, our results do not support the idea that for the translation 
of oncorna virus RNA in vitro specific messenger recognition factors are 
required. 
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PUBLICATION Vi 
TRANSLATION OF ONCOGENIC VIRUS RNA 
IN XEWOPtiS LAEVIS OOCYTES 
Translation of oncogenic virus 
RNA in Xenopus laevis oocytes 
OOCYTE injection as developed by Gurdon et al.''' is 
efficient and reliable for the assay of faithful translation of 
heterologous messenger RNA*"'. But, working in collabora­
tion with Gurdon', we found that oncogenic viral RNA was 
not translated to a detectable extent in oocytes. Only in a 
cell-free system derived from Escherichia coli could we 
translate viral RNA into distinct polypeptides in the 
molecular weight range of the viral group-specific proteins'. 
Recently we achieved translation of Rauscher leukaemia 
virus (RLV) RNA and avian myeloblastosis virus (AMV) 
RNA in various cell-free systems, using immunoprecipita-
tion for the analysis' '°. This verified that our failure to find 
virus-specific polypeptides in the oocyte system programmed 
with oncogenic viral R N A was due to the inadequacy of the 
methods available to detect translation when it occurs at 
low efficiency. We now report the synthesis of AMV-
specific precursors and structural proteins in the oocyte 
system, detected by specific immunoprecipitation and 
scintillation autoradiography. 
AMV contains single stranded RNA encapsulated by 
several proteins and a lipid envelope. The four major pro­
teins, the so-called group-specific (gs) antigens immuno­
logically indistinguishable among all avian oncornaviruses", 
are within the viral envelope". 
There are additional glycosylated proteins, carrying the 
type-specific (ts) antigens, on the surface of the virion". It 
is not known how many proteins are encoded by the viral 
RNA and how many cellular proteins become encapsulated 
in the virions during budding. To determine virus-specific 
proteins it is important to characterise the coding capacity 
of the viral RNA in conditions closely related to the in vivo 
situation. 
The results of a typical translation experiment of AMV 
RNA are shown in Fig. 1. Because of the relatively high 
rate of endogenous protein synthesis of this system, immu­
noprecipitation with specific antisera is a prerequisite for 
detection of the viral proteins. Injection of native 60S 
AMV R N A results in synthesis of virus-specific polypeptides 
with molecular weights of 76,000, 66,000, 32,000, 25,000, 
18,000 and 12,000. In contrast, denatured 35S AMV RNA 
leads to the synthesis of a small quantity of the precursor 
polypeptide with molecular weight 76,000. In chick embryo 
fibroblasts (CEF) infected with AMV the same precursors 
and structural polypeptides are found as have been synthe-
sised after injection of oocytes with native 60S AMV RNA 
(compare Fig. l i and d). 
In addition to the five precursor polypeptides already 
described" we found in AMV-infected CEF a sixth unstable 
precursor of molecular weight 85,000 not present in un­
infected CEF (Fig. 2). This pr85 was, however, not detect­
able after injection of AMV RNA into oocytes. Incubation 
of native 60S AMV R N A in a reticulocyte cell-free system 
(Fig. 3) resulted in the synthesis of the same precursors and 
structural polypeptides found in the oocyte system, but in 
different proportions (compare Figs 1 and 3). In this celf-
free system pr76 is the predominant product and almost no 
cleavage products are present. This probably means that 
the processing of AMV precursors in the oocyte and in 
infected CEF is almost identical, whereas in the reticulocyte 
cell-free system almost no cleavage occurs. In other reti­
culocyte preparations processing of the 76,000-dalton pre­
cursor resembled the situation in vivo (Fig. 4). Whereas 
*-І90 
MP 
*-pr 76 
^ P r 66 
*-50 
— vp25 
—vpl8 
^ v p i 2 
Fig. I Autoradiography of an SDS gel electrophoresis pattern of 
immunoprecipitates. Xenopus laevis oocytes were injected by the 
method of message-injection described by Gurdon et al.1. AMV 
was obtained from viraemic plasma15 and treated with SDS and 
Pronase. The 60S component of AMV RNA was isolated by 
centrifugation in isokinetic glycerol gradients8. Isolated 60S 
AMV RNA was denatured by heating at 100 CC for 3 mm. The 
AMV-specific polypeptides synthesised in the oocytes in the 
presence of 2 μΟ 3SS-methionine (specific activity 478 mCi 
mmol- 1) per oocyte were detected by indirect immunoprecipita­
tion1· with an antiserum directed against the gs antigens of 
AMV. Primary cultures of I χ 10s chick, embryo fibroblasts 
infected with AMV were pulse labelled for 30 mm with 50 \iC\ 
"S-methionine (specific activity 210 Ci mmol- 1) in Earle's 
saline. After lysis in buffer indirect immunoprecipitation was 
carried out to detect virus-specific polypeptides. The immunopre­
cipitates were analysed on sodium dodecyl sulphate (SDSbpoly-
acrylamide slab gel gradients (7-18%) according lo Berns eia/.17. 
After staining and destaining, the slab gel was treated with 
DMSO-PPO18, dried under vacuum and exposed in contact 
with a Kodak X-ray film for 3 d. a. Each of 20 oocytes was 
injected with 25 nl of sterilised distilled water; /?, each of 10 
oocytes was injected with 25 nl of native 60S AMV RNA (1 mg 
ml - 1) in distilled water; c, each of 10 oocytes was injected with 
25 nl of heat-denatured 35S AMV RNA ( Imgrnl"1); d, immuno-
precipitate from pulse-labelled chick embryo fibroblasts infected 
with AMV; e, immunoprecipitate from pulse-labelled uninfected 
chick embryo fibroblasts. PR, precursor polypeptide; VP, virion 
polypeptide. Numerals denote molecular weight in kdaltons. 
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From results obtained in vivo and in vitro we conclude 
that AMV RNA is translated into several precursor poly­
peptides which are cleaved into structural viral proteins, 
presumably by the same relatively unspecific enzymes 
present in chick embryo fibroblasts, oocytes and reticulo­
cytes. We therefore believe that the oocyte system provides 
a useful tool for the study of the regulation processes 
involved in the expression of different viral functions in 
vivo. 
We thank Dr John Gurdon for hospitality to M.S. We 
also thank Mrs Anne-Marie Selten-Versteegen for technical 
assistance, Dr J. W. Beard for viraemic chicken plasma 
and Dr G. de Boer for leukosis-free chick embryos. This 
work was supported in part by the Netherlands Foundation 
for Chemical Research and the Netherlands Organisation 
for Pure Research. 
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Fig. 2 Autoradiograph of an SDS gel electrophoresis pattern of 
immunoprecipitates. Primary cultures of 1 χ IO7 chick embryo 
fibroblasts either uninfected or infected with AMV were pulse 
labelled for 30 mm and immunoprecipttated as described in 
Fig. 1. The immunoprecipitates were analysed on slab gel 
gradients and exposed in contact with a Kodak X-ray film for 3 d. 
a, 1 χ 10T infected cells precipitated with anti-AMV serum, b, 
I χ IO7 uninfected cells precipitated with anti-AMV serum. 
the synthesis of the 76,000-dalton precursor polypeptide in 
a reticulocyte cell-free system is detectable even without 
immunoprecipitation (Fig. 3), as a rule immunoprecipita-
tion procedures are necessary to visualise the small amount 
of virus-specific polypeptides. The specificity of the 
immunoprecipitation was checked as follows. Immuno­
precipitation of control injections without m R N A (Fig. 1), 
by addition of anti-AMV serum, gives rise predominantly 
to two polypeptides with molecular weights of 190,000 and 
50,000. respectively. The latter aspecific polypeptide is also 
always found when the reticulocyte lysate is the assay 
system The same two polypeptides are detected as the only 
components after injection of AMV 60S R N A into the 
oocyte system followed by the addition of an antiserum 
directed against the non-related murine RLV (not shown). 
^ P r 7 6 
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Fig. 3 Autoradlograph of the SDS gel electrophoresis pattern of 
products synthesised in reticulocyte cell-free incubations. Native 
60S AMV RNA was incubated for 60 min at 30 "C in a reticulo­
cyte cell-free system as described elsewhere10. The final incubation 
volume was 25 μΐ. 2 μΙ of the incubation mixture was analysed 
directly on the SDS slab gel and another 20 μΐ was immunoprecipi-
tated1· and analysed. The Kodak X-rayfilm was exposed in contact 
with the dried gel for 2 d. a. Incubation in the reticulocyte cell-
free system with lens MS mRNA; b, control incubation without 
mRNA; c, incubation programmed with native 60S AMV-RNA; 
</, immunoprecipitate of an incubation with native 60S AMV 
RNA; e immunoprecipitate of polypeptides present in pulse 
labelled AM V-infected chick embryo fibroblasts. 
Fig. 4 Autoradiography of immunoprecipitated products syn-
thesised in the reticulocyte cell-free incubation and analysed by 
SDS gel electrophoresis. The analysis of the virus-specific 
polypeptides synthesised in the reticulocyte cell-free system were 
as described in the legend to Fig. 3. The X-ray film was exposed 
in contact with the dried gel for 3 d. a, Immunoprecipitation of 
an incubation in the reticulocyte cell-free system with native 
60S AMV RNA; b, Immunopret ι pitale of an incubation in the 
reticulocyte lysate with denatured 35S AMV RNA. 
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Note added in proof: We have also succeeded in translat­
ing Rauscher leukaemia virus RNA in oocytes. The pre­
cursor of the gs antigens pr65 and the processed polypeptides 
p30 and pi 5 have been detected. 
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SUMMARV 
In cell-free systems 35S RNA from Rauscher murine leukemia virus is trans­
lated into group-specific antigen polypeptides, whereas envelope-related 
products are not detectable. Assuming that no internal initiation takes 
place, this means that the group-specific antigen gene is located at the 
5' end and it may indicate that a sequence: group-specific antigen gene 'ь 
polymerase gene "v envelope glycoprotein gene found in avian sarcoma virus 
also exists in the murine leukemia virus. 
mumcTWN 
C-type viruses contain as their principal RNA component a complex molecule 
with a molecular weight of approximately 6 χ 10 daltons which sediments 
at 60-70S (1-3). When subjected to denaturing conditions this complex dis­
sociates into two subunits with sedimentation coefficients of approximately 
35S and a molecular weight of 3-4 χ 10 (2-5). There is evidence that the 
two subunits contain the same genetic information (6-9). Recently a physi­
cal map of the viral genome has been constructed (10-12). 
Non-defective avian sarcoma viruses have been shown to contain four genetic 
elements, namely the gag-gene, coding for the internal group-specific anti­
gens, the pol-gene, for the reverse transcriptase, the env-gene, coding for 
thç viral envelope glycoprotein, and a gene for the sarcomagenic cell trans-
formation, the ere- or one-gene (9, 12-13). The location of these biological 
functions on the avian viral 35S RNA has been established (10-12). 
Polyribosomes from cells producing R-MuLV contain in addition to 3SS RNA 
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smaller virue-specific species of mRNA (14-18). Translation of these virus-
specific RNA species in a reticulocyte cell-free system resulted in the syn-
thesis of several different immunoprecipitable polypeptides, an indication 
of the presence of different virus messenger classes in cells producing 
R-MuLV (19). 
Recently we have succeeded in translating the viral 35S RNA in different 
cell-free systems and in oocytes from Ke.nopuò ¿azv¿¿ (20-22). However, only 
a portion of the sequences of this virion 35S RNA was translated, as was 
determined by immunoprecipitation analysis of the products of translation 
performed with a polyvalent antiserum directed against R-MuLV. Therefore, 
no definite conclusion could be drawn concerning which types of polypep-
tides were synthesized. In this paper we provide evidence, by analysis with 
monospecific antisera directed against the gag- and env-products, that viral 
35S RNA functions as messenger only for the synthesis of the gag-precursor, 
and, probably due to occasional readthrough, for a high molecular weight 
polypeptide which contains the gag and the adjacent gene, presumably the 
reverse transcriptase. 
MATERIALS AWt» METHODS 
R-MuLV was isolated from the plasma of leukemic mice (23), and treated with 
SDS and pronase. The 65S component of R-MuLV RNA was isolated by centrifu-
gation in an isokinetic glycerol gradient (24) and denatured in 90% formamide 
at ЗО'с for 5 min. The resulting 35S RNA was purified by glycerol gradient 
centrifugation (24). 
Native or denatured R-Mul.V RNA was incubated for 60 min at 300C in a reti­
culocyte cell-free system as described elsewhere (20-21), or injected into 
oocytes from Xenopoi £де -с4 (22). The R-MuLV-specific polypeptides synthe­
sized in these systems were detected by indirect immunoprecipitation with 
polyvalent or monospecific antisera. The rabbit anti-R-MuLV serum was des­
cribed previously (25). Rabbit anti-рЗО and anti-pl5(E),pl2 sera are des­
cribed elsewhere (26). Goat anti-gp69/71 and anti-pl5 sera were described 
by Strand and August (27). The immunoprecipitates were analyzed on Poly­
acrylamide slab gel gradients (7-18%) according to Berns &ƒ af (28). After 
staining and destaining the slab gels were treated with Me.SO-PPO (29), 
dired under vacuum and placed in contact with a Kodak X-ray film for 2-3 
days at -во'С. 
RESULTS AWP PISCUSSIOW 
Vogt e-t of (30-31) have demonstrated that the major internal structural pro­
teins of AMV are formed by cleavage of a common precursor polypeptide, and 
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recently several other groups have reported the biosynthesis of gag- and 
env-precursor polypeptides in C-type virus producing cells (25-26, 32-34). 
The precursor for the env-glycoprotein was found in the 82,000-90,000 mole­
cular weight region on SDS-gels, whereas the gag-precursor was localized at 
65,000-75,000 daltons. 
Addition of oncogenic viral RNA to cell-free systems resulted in the syn­
thesis of several virus-specific polypeptides. These polypeptides can be 
detected after immunoprecipitation with polyvalent antisera directed against 
the viral structural proteins (25), followed by analysis with SDS-gel elec-
torphoresis (20-22). Predominantly two virus-specific polypeptides with mo­
lecular weights of 65,000 and 72,000, respectively, were identified (fig. 1A). 
We wondered whether the 65,000 daltons polypeptide was identical to the gag-
precursor found in infected cells (25-26). Furthermore it had to be eluci­
dated whether the 72,000 daltons polypeptide was related to the gag-pr65 or 
to the env-precursor, since the molecular weight of the non-glycosylated 
protein moiety of the env-precursor might well be 72,000 (34-35). 
In order to discriminate between these alternatives, we determined the com­
petition between the putative labeled gag-related polypeptides, synthesized 
in a cell-free system and immunoprecipitable with a polyvalent antiserum, 
and p30, by adding an excess of unlabeled p30 (the major internal gag-
protein) (26)(fig. IB). It appeared that p30 competed both with the 
65,000 and 72,000 molecular weight polypeptides. Thus both polypeptides 
must contain gag-determinants. Likewise, immunoprecipitation with a 
monospecific antiserum directed against p30 precipitates equally well 
the polypeptides of 65,000 and 72,000 daltons, respectively (fig. 1С). 
Immunoprecipitation with monospecific antisera directed against gp69/71 
or pl5(E),pl2, the proteins that are derived from a common env-precur­
sor (26), did not reveal any virus-specific bands (not shown). There­
fore, we conclude that upon programming cell-free systems with viral 
RNA only polypeptides that are gag-related are synthesized. 
Since no glycosylation takes place ¿n vitAC, we analyzed the virus-
specific polypeptides synthesized in Xenopoâ ¿aeu-tâ oocytes, a system 
which is able to glycosylate polypeptides. Injection of viral 35S RNA 
and immunoprecipitation with polyvalent or monospecific antisera direct-
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1. Autoradiography of an SDS gel electrophoresis pattern of [_ Sj -methionine-
labeled and immunoprecipitated polypeptides which were synthesized in reti­
culocyte cell-free incubations programmed with 35S R-MuLV RNA. 
(A) immunoprecipitation with a polyvalent antiserum directed against R-MuLV; 
(B) immunoprecipitation with a polyvalent antiserum directed against R-MuLV 
after addition of an excess of unlabeled p30 to the incubation mixture; 
(C) immunoprecipitation with a monospecific antiserum directed against puri­
fied p30. 
Г35 Ί . . 
2. Autoradiography of an SDS gel electrophoresis pattern of |_ SJ-methionine-
labeled and immunoprecipitated polypeptides which were synthesized in oocytes 
from Xenopus laevis programmed with 358 RNA. 
Control (no RNA injected). Immunoprecipitations with (A) polyvalent antiserum 
directed against R-MuLV; (B) anti-gp69/71 serum; (C) anti-рЗО serum; (D) anti-
pl5 serum; (E) anti-pl5(E).ріг serum. 
35S R-MuLV RNA injected oocytes immunoprecipitated with (F) polyvalent anti­
serum directed against R-MuLV; (G) anti-gp69/71 serum; (H) anti-рЗО serum; 
(X) anti-pl5 serum; (J) anti-pl5(E),ρΐ2 serum. 
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ed against рЗО or pl5 reveals the synthesis of the 65,000 molecular 
weight gag-precursor (fig. 2F, H and I), whereas monospecific antisera 
directed against gp69/71 or pl5(E),pl2 did not precipitate an env-pre-
cursor or the viral gp69/71 or pl5(E),pl2 (fig. 2G and J). It has recent­
ly been shown that in R-MuLV infected cells this anti-gp69/7l or anti-
pl5(E),pl2 sera precipitate both the common env-precursor and the pro­
cessed viral proteins (26). We conclude that injection of 35S RNA into 
Келораі ¿ЛЫ-іі oocytes leads, as in cell-free systems, exclusively to 
the biosynthesis of gag-related products. In this connexion it has tobe 
mentioned that Mueller-Lantzsch zt at (36) identified 35S RNA as the only 
virus-specific messenger in polyribosomes isolated from virus-infected 
cells. These polyribosomes were immunoprecipitated with an antiserum di­
rected against рЗО. 
The fact that we were unable to detect very large precursor polypeptides 
corresponding to the total viral information does not necessarily mean 
that such a polyprotein does not exist. If its concentration is extremely 
low, e.g. due to rapid processing, it would escape detection. Therefore, 
we investigated the polypeptides synthesized in a reticulocyte cell-free 
system progranmed with R-MuLV RNA, in the presence of a high concentration 
(3 mM) of canavanine, an arginine analog which prevents cleavage of poly­
peptides by trypsin-like enzymes (fig. 3). Instead of a very high molecular 
weight polypeptide, two polypeptides with molecular weights of 72,000 and 
82,000 are synthesized under these conditions, whereas no 65,000 daltons 
polypeptide was present (cf. fig. 3B and 3D). Both polypeptides again were 
precipitable with an anti-p30 or anti-pl5 serum and are, therefore, related 
to the gag-precursor. The observed change in molecular weight of the gag-
polypeptides in the presence of canavanine may be due to prevention of the 
tryptic cleavage or to an altered conformation of the polypeptides. Also 
addition to cell-free systems of a number of known protease inhibitors 
such as TPCK, TLCK or trasylol did not result in the appearence of high 
molecular weight precursors corresponding to the total viral information. 
However, upon programming the reticulocyte lysate with 35S viral RNA a 
small amount of discrete polypeptides are synthesized with molecular 
weights up to 150,000 (fig. 4). These polypeptides are inimunoprecipitable 
90 
-72,000 
-65,000 
.82000 
.72000 
-65,000 
fig. 3. Autoradiography of an SDS gel electrophoresis pattern of [ Sj -methionine-
labeled and immunoprecipitated polypeptides which were synthesized in reti-
culocyte cell-free incubations programmed with native or denatured R-MuLV RN. 
Virus-specific polypeptides synthesized in the absence of canavanine after 
addition of (A) native, or (B) denatured viral RNA. 
Virus-specific polypeptides synthesized in the presence of canavanine after 
addition of (C) native, or (D) denatured viral RNA. 
fig. 4. Autoradiography of an SDS gel electrophoresis pattern of [_ s| -methionine-
labeled polypeptides synthesized in a reticulocyte cell-free system and im-
munoprecipitable with a polyvalent antiserum directed against R-MuLV. 
Immunoprecipitated products synthesized after addition of (A) 35S, or (B) 
65S R-MuLV RNA. 
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with anti-рЗО serum but not with anti-gp69/71 serum. Taking into account 
the recently proposed gene order gag-pol-env (10-12, 37), our results 
suggest that these high molecular weight polypeptides contain the gag-
precursor linked to the reverse transcriptase. The synthesis of this high 
molecular weight polypeptide may be due to occasional readthrough at the 
termination site of the gag-gene (cf. réf. ЗА). 
Our findings can be explained by the assumption that, whereas 35S viral 
RNA directs mainly the synthesis of the gag-precursor, a readthrough me­
chanism occurring at low frequency is responsible for the production of 
a small amount of a gag-pol precursor. This would also explain the rela­
tive low concentration of reverse transcriptase synthesized as compared 
with the gag-products. Since, obviously, 35S RNA does not direct the syn­
thesis of env-related products, it has to be established whether virus-
specific mRNAs with lower sedimentation values (which have been found on 
polyribosomes from virus-infected cells (14-18)) are responsible for the 
formation of env-polypeptides. 
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SUMMARY 
This thesis contains a number of publications dealing with the mole-
cular biology of oncogenic RNA viruses. Considerable progress has recent-
ly been made in analyzing the organization of the viral genome and pro-
teins as well as the reverse transcription of the viral genome into the 
proviral DNA. 
In the General Introduction (chapter 1) it is discussed that the 
virus particles possess two identical RNA subunits each containing four 
genetic elements, namely a gene coding for the internal group-specific 
antigens (gag-gene), a gene for the reverse transcriptase (po£-gene), a 
gene for the envelope proteins (enu-gene), and a gene coding for the pro-
ducts responsible for the sarcomagenic cell transformation (¿л.с- or one-
gene). These genes seem to be arranged in this sequence. 
In order to determine the coding capacity of the tumor virus genome 
we translated R-MuLV - , MMTV - , and AMV-RNA in a cell-free system derived 
from E.co-Lt. In this system only low molecular weight polypeptides rela­
ted to the internal gag-gene products were synthesized (chapter 3). 
Several investigators claimed that both specific protein factors as 
well as RNA species are required for proper initiation of viral and mam­
malian mRNA in heterologous cell-free systems. We found that polyamines 
could mimic the action of some of these RNA factors (chapter 4). 
In chapter 5 evidence for the faithful translation of oncogenic vi­
rus RNA in heterologous systems is presented. Analysis of the virus-spe­
cific polypeptides synthesized in these systems revealed that only gag-
gene related products are synthesized. This would indicate that, whereas 
the virus RNA contains several genetic elements, probably no internal 
initiation can occur and, therefore, that the virus RNA behaves like a 
functionally monocistroni с messenger. 
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STELLINGEN 
I 
Het product van het Fv-1 gen van de muis, dat de efficiëntie van exogene infectie 
door muize-leukemieviiussen bepaalt, is waarschijnlijk een remmer van een nog niet 
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II 
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buline G, hetgeen kan leiden tot immunologische enhancement. 
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Ill 
Bij de in vitro studies naar de omzetting van "single-stranded" circulair φΧ 174 DNA 
in de "double-stranded" circulaire replicatieve vorm is onvoldoende rekening gehou­
den met een poly enzym functie van het drwG gen product. 
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IV 
Daar uit recent onderzoek is gebleken dat er grote verschillen bestaan in de celkine-
tiek van leukemisch beenmerg en de farmacokinetiek van bepaalde cytostatica, die 
worden toegepast bij de behandeling van patiënten met acute meyeloïde leukemie, 
lijkt individualisering van de cytostatische therapie gewenst. 
L.B. Mellett, In Proc. 5th Int. Congr. Pharmacol, pg. 332-353 (G.T. Okita and 
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ν 
Uit de experimentele gegevens van Schwartz en Darnell kan niet worden geconclu­
deerd .dat het eiwit met een molecuulgewicht van 75.000, geassocieerd met het poly 
A-gedeelte van HeLa-celmessengei RNA's, een rol speelt bij het transport van deze 
messengers. 
H. Schwartz and J.E. Darnell, J. Mol. Biol. 104, 833-851 (1976). 
VI 
De injectie-experimenten in Xenopus laevis eieren met plante-RNA-extracten bewij­
zen niet dat de novo gesynthetiseerde Polypeptiden verantwoordelijk zijn voor de 
mcompatibiliteitsreactie bij Petunia hybrida. 
J.A.W.M. v.d. Donk, Nature 256, 674-675 (1975). 
VII 
Bij immunisatie met levende vaccins dient men rekening te houden met de aan­
wezigheid van oncogene virussen in deze vaccins en de mogelijke inductie van persis­
terende virusinfecties, die aanleiding kunnen geven tot de ontwikkeling van "auto-
inmuunziekten". 
V.M. Zhdanov, Nature 256, 471-473 (1975). 
VIII 
Op klinische laboratoria worden dorpels nog te veel beschouwd als wildroosters voor 
hepatitisvirus. 
M.H.L. Salden Nijmegen, 21 oktober 1976 



